TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-71384	Ethanol oxidation	3.80817103397938e-06	-12.4783615276584	12	5	0.0216450216450216	231	10287	216,125,126,130,127	ALDH1A1,ADH1B,ADH1C,ADH6,ADH4
R-HSA-397014	Muscle contraction	1.38176383725061e-05	-11.1895646389952	204	16	0.0692640692640693	231	10287	6327,4638,25802,6546,60598,482,7140,775,10398,7136,4634,816,89822,6326,6329,4632	SCN2B,MYLK,LMOD1,SLC8A1,KCNK15,ATP1B2,TNNT3,CACNA1C,MYL9,TNNI2,MYL3,CAMK2B,KCNK17,SCN2A,SCN4A,MYL1
R-HSA-211945	Phase 1 - Functionalization of compounds	3.19884432710844e-05	-10.3501358681727	109	11	0.0476190476190476	231	10287	66002,5740,2327,126,127,125,64757,130,2326,216,51302	CYP4F12,PTGIS,FMO2,ADH1C,ADH4,ADH1B,MARC1,ADH6,FMO1,ALDH1A1,CYP39A1
R-HSA-5632681	Ligand-receptor interactions	0.00057582551187651	-7.45970587393113	8	3	0.012987012987013	231	10287	64399,2619,3549	HHIP,GAS1,IHH
R-HSA-418346	Platelet homeostasis	0.000980224366681858	-6.92772906690997	91	8	0.0346320346320346	231	10287	9127,338,8654,5023,5136,5593,6546,2788	P2RX6,APOB,PDE5A,P2RX1,PDE1A,PRKG2,SLC8A1,GNG7
R-HSA-382551	Transmembrane transport of small molecules	0.00123527388958714	-6.69646256054512	677	28	0.121212121212121	231	10287	79895,2030,121601,10991,53919,6546,364,23539,107,482,8001,55089,5172,55867,225,41,22802,6563,2788,816,1188,10396,30061,55283,5244,360,6508,25769	ATP8B4,SLC29A1,ANO4,SLC38A3,SLCO1C1,SLC8A1,AQP7,SLC16A8,ADCY1,ATP1B2,GLRA3,SLC38A4,SLC26A4,SLC22A11,ABCD2,ASIC1,CLCA4,SLC14A1,GNG7,CAMK2B,CLCNKB,ATP8A1,SLC40A1,MCOLN3,ABCB4,AQP3,SLC4A3,SLC24A2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.00131811349069872	-6.63155373833979	22	4	0.0173160173160173	231	10287	8325,8549,343637,340419	FZD8,LGR5,RSPO4,RSPO2
R-HSA-217271	FMO oxidises nucleophiles	0.00148399003111865	-6.51302085183454	3	2	0.00865800865800866	231	10287	2326,2327	FMO1,FMO2
R-HSA-211859	Biological oxidations	0.0014940354155753	-6.50627448734812	222	13	0.0562770562770563	231	10287	126,2327,66002,2946,2953,5740,130,64757,125,216,51302,2326,127	ADH1C,FMO2,CYP4F12,GSTM2,GSTT2,PTGIS,ADH6,MARC1,ADH1B,ALDH1A1,CYP39A1,FMO1,ADH4
R-HSA-2029485	Role of phospholipids in phagocytosis	0.00251102928810041	-5.98706253495579	26	4	0.0173160173160173	231	10287	5295,122618,2209,2214	PIK3R1,PLD4,FCGR1A,FCGR3A
R-HSA-3781865	Diseases of glycosylation	0.00293754665918902	-5.83018051565877	85	7	0.0303030303030303	231	10287	143662,10417,157869,9719,4958,7057,6382	MUC15,SPON2,SBSPON,ADAMTSL2,OMD,THBS1,SDC1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.00332051118884398	-5.70763653536293	28	4	0.0173160173160173	231	10287	113026,51196,122618,5330	PLCD3,PLCE1,PLD4,PLCB2
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.0033873812970465	-5.68769813485257	14	3	0.012987012987013	231	10287	5740,11001,51302	PTGIS,SLC27A2,CYP39A1
R-HSA-1430728	Metabolism	0.00347974069554489	-5.66079750074643	2158	66	0.285714285714286	231	10287	117245,8908,33,51196,775,5740,5260,107,23539,125,760,29881,374569,948,54511,415,5244,51477,162466,7069,2593,126,57571,788,54,11001,2326,130,5224,165679,129807,4958,2327,338,151742,51302,64757,5166,127,5167,5169,2953,147323,113026,66002,3158,375775,5053,2875,5593,1757,55825,6382,216,122618,2788,51171,5295,1490,2946,1149,7351,5105,26289,5330,10840	PLAAT5,GYG2,ACADL,PLCE1,CACNA1C,PTGIS,PHKG1,ADCY1,SLC16A8,ADH1B,CA2,NPC1L1,ASPG,CD36,HMGCLL1,ARSE,ABCB4,ISYNA1,PHOSPHO1,THRSP,GAMT,ADH1C,CARNS1,SLC25A20,ACP5,SLC27A2,FMO1,ADH6,PGAM2,SPTSSB,NEU4,OMD,FMO2,APOB,PPM1L,CYP39A1,MARC1,PDK4,ADH4,ENPP1,ENPP3,GSTT2,STARD6,PLCD3,CYP4F12,HMGCS2,PNPLA7,PAH,GPT,PRKG2,SARDH,PECR,SDC1,ALDH1A1,PLD4,GNG7,HSD17B14,PIK3R1,CCN2,GSTM2,CIDEA,UCP2,PCK1,AK5,PLCB2,ALDH1L1
R-HSA-5576892	Phase 0 - rapid depolarisation	0.0038910866820603	-5.54906680764876	47	5	0.0216450216450216	231	10287	6326,6327,775,6329,816	SCN2A,SCN2B,CACNA1C,SCN4A,CAMK2B
R-HSA-1483249	Inositol phosphate metabolism	0.0038910866820603	-5.54906680764876	47	5	0.0216450216450216	231	10287	51477,113026,5330,122618,51196	ISYNA1,PLCD3,PLCB2,PLD4,PLCE1
R-HSA-445095	Interaction between L1 and Ankyrins	0.00429145441701741	-5.4511295785524	30	4	0.0173160173160173	231	10287	6329,6327,6326,288	SCN4A,SCN2B,SCN2A,ANK3
R-HSA-5576891	Cardiac conduction	0.00468197321338935	-5.36403563111958	142	9	0.038961038961039	231	10287	6327,6546,816,6326,482,60598,89822,775,6329	SCN2B,SLC8A1,CAMK2B,SCN2A,ATP1B2,KCNK15,KCNK17,CACNA1C,SCN4A
R-HSA-3000471	Scavenging by Class B Receptors	0.00480126488228719	-5.33887587863967	5	2	0.00865800865800866	231	10287	948,338	CD36,APOB
R-HSA-5686938	Regulation of TLR by endogenous ligand	0.00504159590452938	-5.29003259929709	16	3	0.012987012987013	231	10287	929,338,948	CD14,APOB,CD36
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.00602156986092749	-5.11240727941665	17	3	0.012987012987013	231	10287	816,2905,2891	CAMK2B,GRIN2C,GRIA2
R-HSA-390522	Striated Muscle Contraction	0.00677213746329914	-4.99493851614303	34	4	0.0173160173160173	231	10287	4632,7140,7136,4634	MYL1,TNNT3,TNNI2,MYL3
R-HSA-8851907	MET activates PI3K/AKT signaling	0.00709557787296673	-4.94828352377045	6	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-418457	cGMP effects	0.00710755021756109	-4.94659764903164	18	3	0.012987012987013	231	10287	5593,5136,8654	PRKG2,PDE1A,PDE5A
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.00915331140464582	-4.69363956301841	37	4	0.0173160173160173	231	10287	10417,157869,9719,7057	SPON2,SBSPON,ADAMTSL2,THBS1
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.00978742895933534	-4.62665647599701	7	2	0.00865800865800866	231	10287	54,5167	ACP5,ENPP1
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.0102275566944215	-4.58266956484473	59	5	0.0216450216450216	231	10287	10417,143662,157869,9719,7057	SPON2,MUC15,SBSPON,ADAMTSL2,THBS1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.0110098188294873	-4.50896778347038	39	4	0.0173160173160173	231	10287	7057,157869,10417,9719	THBS1,SBSPON,SPON2,ADAMTSL2
R-HSA-112316	Neuronal System	0.0121736867462479	-4.40847848061587	349	15	0.0649350649350649	231	10287	107,2036,127833,89822,2905,2891,3764,3787,83988,2788,3739,5330,7881,816,9256	ADCY1,EPB41L1,SYT2,KCNK17,GRIN2C,GRIA2,KCNJ8,KCNS1,NCALD,GNG7,KCNA4,PLCB2,KCNAB1,CAMK2B,TSPOAP1
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.0125588112838143	-4.37733276542944	22	3	0.012987012987013	231	10287	2162,2147,2149	F13A1,F2,F2R
R-HSA-77111	Synthesis of Ketone Bodies	0.012857963441389	-4.35379193652466	8	2	0.00865800865800866	231	10287	54511,3158	HMGCLL1,HMGCS2
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.0130931714609124	-4.33566444720534	41	4	0.0173160173160173	231	10287	2905,816,107,2891	GRIN2C,CAMK2B,ADCY1,GRIA2
R-HSA-5365859	RA biosynthesis pathway	0.0142074652112141	-4.25398773341721	23	3	0.012987012987013	231	10287	127,216,126	ADH4,ALDH1A1,ADH1C
R-HSA-5654695	PI-3K cascade:FGFR2	0.0142074652112141	-4.25398773341721	23	3	0.012987012987013	231	10287	2252,5295,2549	FGF7,PIK3R1,GAB1
R-HSA-5173105	O-linked glycosylation	0.0142187108663141	-4.25319651509393	114	7	0.0303030303030303	231	10287	7057,374907,256435,10417,157869,143662,9719	THBS1,B3GNT8,ST6GALNAC3,SPON2,SBSPON,MUC15,ADAMTSL2
R-HSA-109582	Hemostasis	0.0149449900348087	-4.20337915003744	632	23	0.0995670995670996	231	10287	5136,3798,8654,6382,285,5023,9127,338,7057,2788,2147,113220,5295,2149,2625,2162,482,4352,23539,6546,5593,4778,948	PDE1A,KIF5A,PDE5A,SDC1,ANGPT2,P2RX1,P2RX6,APOB,THBS1,GNG7,F2,KIF12,PIK3R1,F2R,GATA3,F13A1,ATP1B2,MPL,SLC16A8,SLC8A1,PRKG2,NFE2,CD36
R-HSA-5362517	Signaling by Retinoic Acid	0.0154121787395755	-4.17259725485649	43	4	0.0173160173160173	231	10287	5166,127,126,216	PDK4,ADH4,ADH1C,ALDH1A1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.0159730234668037	-4.13685401302097	24	3	0.012987012987013	231	10287	5593,8654,5136	PRKG2,PDE5A,PDE1A
R-HSA-74182	Ketone body metabolism	0.0162889666295558	-4.11726729425781	9	2	0.00865800865800866	231	10287	3158,54511	HMGCS2,HMGCLL1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.0170797122198179	-4.06986393972046	146	8	0.0346320346320346	231	10287	2891,816,5330,2788,83988,2036,107,2905	GRIA2,CAMK2B,PLCB2,GNG7,NCALD,EPB41L1,ADCY1,GRIN2C
R-HSA-983712	Ion channel transport	0.0195022523062468	-3.93722531719793	209	10	0.0432900432900433	231	10287	1188,10396,816,79895,41,22802,121601,55283,482,8001	CLCNKB,ATP8A1,CAMK2B,ATP8B4,ASIC1,CLCA4,ANO4,MCOLN3,ATP1B2,GLRA3
R-HSA-168799	Neurotoxicity of clostridium toxins	0.0200628448079498	-3.9088856915505	10	2	0.00865800865800866	231	10287	9899,127833	SV2B,SYT2
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.0200628448079498	-3.9088856915505	10	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0222892228117188	-3.80365199932014	48	4	0.0173160173160173	231	10287	2049,2042,2051,2044	EPHB3,EPHA3,EPHB6,EPHA5
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.0241626067289244	-3.72294901732659	11	2	0.00865800865800866	231	10287	7069,788	THRSP,SLC25A20
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.0241626067289244	-3.72294901732659	11	2	0.00865800865800866	231	10287	948,929	CD36,CD14
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.0241626067289244	-3.72294901732659	11	2	0.00865800865800866	231	10287	929,948	CD14,CD36
R-HSA-5655291	Signaling by FGFR4 in disease	0.0241626067289244	-3.72294901732659	11	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-1296071	Potassium Channels	0.0249257700645978	-3.69185306834176	100	6	0.025974025974026	231	10287	3787,3764,89822,3739,2788,7881	KCNS1,KCNJ8,KCNK17,KCNA4,GNG7,KCNAB1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0256687753827605	-3.66247999140144	813	27	0.116883116883117	231	10287	151742,51302,122618,162466,7069,129807,415,5244,338,11001,29881,375775,1149,55825,1757,948,165679,54511,117245,5295,51171,33,1490,5740,788,147323,3158	PPM1L,CYP39A1,PLD4,PHOSPHO1,THRSP,NEU4,ARSE,ABCB4,APOB,SLC27A2,NPC1L1,PNPLA7,CIDEA,PECR,SARDH,CD36,SPTSSB,HMGCLL1,PLAAT5,PIK3R1,HSD17B14,ACADL,CCN2,PTGIS,SLC25A20,STARD6,HMGCS2
R-HSA-425407	SLC-mediated transmembrane transport	0.02851040696735	-3.55748610161191	287	12	0.051948051948052	231	10287	2030,6563,10991,6546,53919,23539,55089,30061,55867,5172,6508,25769	SLC29A1,SLC14A1,SLC38A3,SLC8A1,SLCO1C1,SLC16A8,SLC38A4,SLC40A1,SLC22A11,SLC26A4,SLC4A3,SLC24A2
R-HSA-211979	Eicosanoids	0.0285718456175625	-3.55533346498125	12	2	0.00865800865800866	231	10287	5740,66002	PTGIS,CYP4F12
R-HSA-445717	Aquaporin-mediated transport	0.028948452572841	-3.54223852810706	52	4	0.0173160173160173	231	10287	2788,364,360,107	GNG7,AQP7,AQP3,ADCY1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.0290503589313814	-3.53872444011919	30	3	0.012987012987013	231	10287	5295,2252,2549	PIK3R1,FGF7,GAB1
R-HSA-418360	Platelet calcium homeostasis	0.0316441316859429	-3.45320256034944	31	3	0.012987012987013	231	10287	9127,6546,5023	P2RX6,SLC8A1,P2RX1
R-HSA-5339562	Uptake and actions of bacterial toxins	0.0316441316859429	-3.45320256034944	31	3	0.012987012987013	231	10287	127833,5608,9899	SYT2,MAP2K6,SV2B
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.0332694737537743	-3.40311500651676	107	6	0.025974025974026	231	10287	55089,10991,6546,5172,6508,25769	SLC38A4,SLC38A3,SLC8A1,SLC26A4,SLC4A3,SLC24A2
R-HSA-432047	Passive transport by Aquaporins	0.0332747216760406	-3.40295727909235	13	2	0.00865800865800866	231	10287	360,364	AQP3,AQP7
R-HSA-2029481	FCGR activation	0.0332747216760406	-3.40295727909235	13	2	0.00865800865800866	231	10287	2209,2214	FCGR1A,FCGR3A
R-HSA-425561	Sodium/Calcium exchangers	0.0332747216760406	-3.40295727909235	13	2	0.00865800865800866	231	10287	25769,6546	SLC24A2,SLC8A1
R-HSA-202733	Cell surface interactions at the vascular wall	0.0335230263101912	-3.39552272372666	136	7	0.0303030303030303	231	10287	5295,23539,6382,285,338,2147,482	PIK3R1,SLC16A8,SDC1,ANGPT2,APOB,F2,ATP1B2
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.0343551467645478	-3.37100343850858	32	3	0.012987012987013	231	10287	2788,83988,5330	GNG7,NCALD,PLCB2
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.0343551467645478	-3.37100343850858	32	3	0.012987012987013	231	10287	816,2036,2891	CAMK2B,EPB41L1,GRIA2
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.0343551467645478	-3.37100343850858	32	3	0.012987012987013	231	10287	2147,2788,2149	F2,GNG7,F2R
R-HSA-399719	Trafficking of AMPA receptors	0.0343551467645478	-3.37100343850858	32	3	0.012987012987013	231	10287	816,2036,2891	CAMK2B,EPB41L1,GRIA2
R-HSA-4085001	Sialic acid metabolism	0.0371826037528309	-3.29191426813415	33	3	0.012987012987013	231	10287	256435,338596,129807	ST6GALNAC3,ST8SIA6,NEU4
R-HSA-422475	Axon guidance	0.040122790869403	-3.21581075526186	549	19	0.0822510822510823	231	10287	5295,55740,2905,2044,4684,775,6327,2049,2252,2051,3815,2549,6326,288,6329,10398,54209,816,2042	PIK3R1,ENAH,GRIN2C,EPHA5,NCAM1,CACNA1C,SCN2B,EPHB3,FGF7,EPHB6,KIT,GAB1,SCN2A,ANK3,SCN4A,MYL9,TREM2,CAMK2B,EPHA3
R-HSA-192105	Synthesis of bile acids and bile salts	0.0401255521026377	-3.21574193805932	34	3	0.012987012987013	231	10287	51302,11001,5740	CYP39A1,SLC27A2,PTGIS
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0401255521026377	-3.21574193805932	34	3	0.012987012987013	231	10287	10398,2042,2044	MYL9,EPHA3,EPHA5
R-HSA-936837	Ion transport by P-type ATPases	0.0409339344288098	-3.19579586730211	58	4	0.0173160173160173	231	10287	482,79895,10396,816	ATP1B2,ATP8B4,ATP8A1,CAMK2B
R-HSA-111885	Opioid Signalling	0.0421502320076385	-3.16651509021636	85	5	0.0216450216450216	231	10287	84152,107,5330,5136,2788	PPP1R1B,ADCY1,PLCB2,PDE1A,GNG7
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.0444089362098596	-3.11431456380741	2	1	0.00432900432900433	231	10287	89822	KCNK17
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.0444089362098596	-3.11431456380741	2	1	0.00432900432900433	231	10287	929	CD14
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.0444089362098596	-3.11431456380741	2	1	0.00432900432900433	231	10287	5740	PTGIS
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.0444089362098596	-3.11431456380741	2	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.0444089362098596	-3.11431456380741	2	1	0.00432900432900433	231	10287	364	AQP7
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.0444089362098596	-3.11431456380741	2	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-418555	G alpha (s) signalling events	0.0463129746166093	-3.07233312784643	146	7	0.0303030303030303	231	10287	5745,27115,107,10268,5136,8622,2788	PTH1R,PDE7B,ADCY1,RAMP3,PDE1A,PDE8B,GNG7
R-HSA-445355	Smooth Muscle Contraction	0.0463534288215029	-3.07146001297496	36	3	0.012987012987013	231	10287	25802,4638,10398	LMOD1,MYLK,MYL9
R-HSA-1963642	PI3K events in ERBB2 signaling	0.048994925618274	-3.01603854504483	16	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.048994925618274	-3.01603854504483	16	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.048994925618274	-3.01603854504483	16	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-438064	Post NMDA receptor activation events	0.0496357921220177	-3.00304309012717	37	3	0.012987012987013	231	10287	107,2905,816	ADCY1,GRIN2C,CAMK2B
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.0530285343265523	-2.93692512678657	38	3	0.012987012987013	231	10287	50507,2878,6648	NOX4,GPX3,SOD2
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.0547247063864301	-2.90544000084242	17	2	0.00865800865800866	231	10287	816,2905	CAMK2B,GRIN2C
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.0547247063864301	-2.90544000084242	17	2	0.00865800865800866	231	10287	5023,9127	P2RX1,P2RX6
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.0547247063864301	-2.90544000084242	17	2	0.00865800865800866	231	10287	5167,5169	ENPP1,ENPP3
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.0547247063864301	-2.90544000084242	17	2	0.00865800865800866	231	10287	8908,5260	GYG2,PHKG1
R-HSA-373080	Class B/2 (Secretin family receptors)	0.0558535072276244	-2.88502295816689	92	5	0.0216450216450216	231	10287	2788,10268,8325,5745,3549	GNG7,RAMP3,FZD8,PTH1R,IHH
R-HSA-112315	Transmission across Chemical Synapses	0.055991703879656	-2.88255174422769	217	9	0.038961038961039	231	10287	2891,5330,816,9256,2788,83988,2036,107,2905	GRIA2,PLCB2,CAMK2B,TSPOAP1,GNG7,NCALD,EPB41L1,ADCY1,GRIN2C
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.0565300939504365	-2.87298214633919	39	3	0.012987012987013	231	10287	2162,2147,2149	F13A1,F2,F2R
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0579772946267534	-2.84770381703339	65	4	0.0173160173160173	231	10287	2252,5295,3815,2549	FGF7,PIK3R1,KIT,GAB1
R-HSA-210993	Tie2 Signaling	0.0606768509080333	-2.80219302255196	18	2	0.00865800865800866	231	10287	5295,285	PIK3R1,ANGPT2
R-HSA-5654710	PI-3K cascade:FGFR3	0.0606768509080333	-2.80219302255196	18	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-5635838	Activation of SMO	0.0606768509080333	-2.80219302255196	18	2	0.00865800865800866	231	10287	2619,3549	GAS1,IHH
R-HSA-375276	Peptide ligand-binding receptors	0.0614821971222766	-2.78900762376298	188	8	0.0346320346320346	231	10287	886,2147,7504,2359,6755,2149,4987,51554	CCKAR,F2,XK,FPR3,SSTR5,F2R,OPRL1,ACKR4
R-HSA-2682334	EPH-Ephrin signaling	0.0624267330327166	-2.77376168136398	95	5	0.0216450216450216	231	10287	2042,2051,2044,2049,10398	EPHA3,EPHB6,EPHA5,EPHB3,MYL9
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	33	ACADL
R-HSA-265473	Trafficking of dietary sterols	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	29881	NPC1L1
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	2735	GLI1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	127833	SYT2
R-HSA-5357572	Lysosomal glycogen catabolism	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	3549	IHH
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	57134	MAN1C1
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.0658714092996611	-2.72005078139125	3	1	0.00432900432900433	231	10287	9899	SV2B
R-HSA-3928664	Ephrin signaling	0.0668385801419861	-2.70547481811992	19	2	0.00865800865800866	231	10287	2051,2049	EPHB6,EPHB3
R-HSA-5576886	Phase 4 - resting membrane potential	0.0668385801419861	-2.70547481811992	19	2	0.00865800865800866	231	10287	89822,60598	KCNK17,KCNK15
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.0668385801419861	-2.70547481811992	19	2	0.00865800865800866	231	10287	2905,816	GRIN2C,CAMK2B
R-HSA-1474244	Extracellular matrix organization	0.0701454151573485	-2.65718483226952	296	11	0.0476190476190476	231	10287	50859,7057,54829,8200,7143,4684,6382,827,81578,11131,4237	SPOCK3,THBS1,ASPN,GDF5,TNR,NCAM1,SDC1,CAPN6,COL21A1,CAPN11,MFAP2
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.0715900379361654	-2.63679934966546	43	3	0.012987012987013	231	10287	2788,360,107	GNG7,AQP3,ADCY1
R-HSA-5655253	Signaling by FGFR2 in disease	0.0715900379361654	-2.63679934966546	43	3	0.012987012987013	231	10287	2549,2252,5295	GAB1,FGF7,PIK3R1
R-HSA-194068	Bile acid and bile salt metabolism	0.0715900379361654	-2.63679934966546	43	3	0.012987012987013	231	10287	11001,51302,5740	SLC27A2,CYP39A1,PTGIS
R-HSA-3000170	Syndecan interactions	0.0731975724610125	-2.6145930216657	20	2	0.00865800865800866	231	10287	6382,7057	SDC1,THBS1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.0731975724610125	-2.6145930216657	20	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-5654720	PI-3K cascade:FGFR4	0.0731975724610125	-2.6145930216657	20	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-418217	G beta:gamma signalling through PLC beta	0.0731975724610125	-2.6145930216657	20	2	0.00865800865800866	231	10287	2788,5330	GNG7,PLCB2
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.0731975724610125	-2.6145930216657	20	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-1643713	Signaling by EGFR in Cancer	0.0731975724610125	-2.6145930216657	20	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-1296072	Voltage gated Potassium channels	0.0756091242154488	-2.58217831239864	44	3	0.012987012987013	231	10287	3739,7881,3787	KCNA4,KCNAB1,KCNS1
R-HSA-373760	L1CAM interactions	0.0768265267077798	-2.56620529862442	101	5	0.0216450216450216	231	10287	6326,288,6327,4684,6329	SCN2A,ANK3,SCN2B,NCAM1,SCN4A
R-HSA-162582	Signal Transduction	0.0778804344873569	-2.55258051956	2548	67	0.29004329004329	231	10287	1124,5295,2149,2905,3549,2252,7504,3249,2549,27334,115703,9241,343637,51554,5745,64388,5330,6017,5593,4638,84152,80835,3815,340419,55553,54763,10811,6382,2670,3714,886,57449,816,8549,216,84894,64399,2788,4987,126,27115,57569,338,2359,5136,401541,80310,80004,5166,56656,127,7057,8622,22943,107,144165,10268,4684,80319,8325,6755,3798,10398,2147,2619,84033,2735	CHN2,PIK3R1,F2R,GRIN2C,IHH,FGF7,XK,HPN,GAB1,P2RY10,ARHGAP33,NOG,RSPO4,ACKR4,PTH1R,GREM2,PLCB2,RLBP1,PRKG2,MYLK,PPP1R1B,TAS1R1,KIT,RSPO2,SOX6,ROPN1,NOXA1,SDC1,GFAP,JAG2,CCKAR,PLEKHG5,CAMK2B,LGR5,ALDH1A1,LINGO1,HHIP,GNG7,OPRL1,ADH1C,PDE7B,ARHGAP20,APOB,FPR3,PDE1A,CENPP,PDGFD,ESRP2,PDK4,OR2S2,ADH4,THBS1,PDE8B,DKK1,ADCY1,PRICKLE1,RAMP3,NCAM1,CXXC4,FZD8,SSTR5,KIF5A,MYL9,F2,GAS1,OBSCN,GLI1
R-HSA-5654689	PI-3K cascade:FGFR1	0.0797419496823434	-2.52895948683444	21	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-500657	Presynaptic function of Kainate receptors	0.0797419496823434	-2.52895948683444	21	2	0.00865800865800866	231	10287	2788,5330	GNG7,PLCB2
R-HSA-2672351	Stimuli-sensing channels	0.0846445602211247	-2.46929443447468	104	5	0.0216450216450216	231	10287	41,22802,121601,55283,1188	ASIC1,CLCA4,ANO4,MCOLN3,CLCNKB
R-HSA-500792	GPCR ligand binding	0.0855534894671327	-2.45861349084768	453	15	0.0649350649350649	231	10287	886,3549,5745,2147,7504,80835,2788,2359,8325,27334,6755,4987,10268,2149,51554	CCKAR,IHH,PTH1R,F2,XK,TAS1R1,GNG7,FPR3,FZD8,P2RY10,SSTR5,OPRL1,RAMP3,F2R,ACKR4
R-HSA-5655332	Signaling by FGFR3 in disease	0.0864602635211974	-2.44807035185003	22	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.0864602635211974	-2.44807035185003	22	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.0868538776437671	-2.44352813969507	4	1	0.00432900432900433	231	10287	10370	CITED2
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.0868538776437671	-2.44352813969507	4	1	0.00432900432900433	231	10287	9899	SV2B
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.0868538776437671	-2.44352813969507	4	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-399710	Activation of AMPA receptors	0.0868538776437671	-2.44352813969507	4	1	0.00432900432900433	231	10287	2891	GRIA2
R-HSA-1296025	ATP sensitive Potassium channels	0.0868538776437671	-2.44352813969507	4	1	0.00432900432900433	231	10287	3764	KCNJ8
R-HSA-3000497	Scavenging by Class H Receptors	0.0868538776437671	-2.44352813969507	4	1	0.00432900432900433	231	10287	338	APOB
R-HSA-5654738	Signaling by FGFR2	0.0878950107816041	-2.4316122360657	75	4	0.0173160173160173	231	10287	5295,2252,2549,80004	PIK3R1,FGF7,GAB1,ESRP2
R-HSA-112043	PLC beta mediated events	0.0882439400593996	-2.42765025340863	47	3	0.012987012987013	231	10287	107,5136,5330	ADCY1,PDE1A,PLCB2
R-HSA-112040	G-protein mediated events	0.0926409212104593	-2.37902432122525	48	3	0.012987012987013	231	10287	5136,5330,107	PDE1A,PLCB2,ADCY1
R-HSA-5627123	RHO GTPases activate PAKs	0.0933414824080403	-2.37149065677771	23	2	0.00865800865800866	231	10287	10398,4638	MYL9,MYLK
R-HSA-196854	Metabolism of vitamins and cofactors	0.097088160448517	-2.33213584264829	174	7	0.0303030303030303	231	10287	10840,338,5740,5169,5167,6382,54	ALDH1L1,APOB,PTGIS,ENPP3,ENPP1,SDC1,ACP5
R-HSA-5260271	Diseases of Immune System	0.100374978676759	-2.29884231915101	24	2	0.00865800865800866	231	10287	929,948	CD14,CD36
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.100374978676759	-2.29884231915101	24	2	0.00865800865800866	231	10287	929,948	CD14,CD36
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.100374978676759	-2.29884231915101	24	2	0.00865800865800866	231	10287	5740,11001	PTGIS,SLC27A2
R-HSA-201451	Signaling by BMP	0.100374978676759	-2.29884231915101	24	2	0.00865800865800866	231	10287	64388,9241	GREM2,NOG
R-HSA-6785807	Interleukin-4 and 13 signaling	0.104441429587023	-2.25912884712709	111	5	0.0216450216450216	231	10287	2162,948,6097,5295,2625	F13A1,CD36,RORC,PIK3R1,GATA3
R-HSA-397795	G-protein beta:gamma signalling	0.106356800012708	-2.24095579943913	51	3	0.012987012987013	231	10287	5330,5295,2788	PLCB2,PIK3R1,GNG7
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	7351	UCP2
R-HSA-561048	Organic anion transport	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	55867	SLC22A11
R-HSA-70350	Fructose catabolism	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	216	ALDH1A1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	57134	MAN1C1
R-HSA-8852405	Signaling by MST1	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	3249	HPN
R-HSA-167827	The proton buffering model	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	7351	UCP2
R-HSA-389599	Alpha-oxidation of phytanate	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	11001	SLC27A2
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	9899	SV2B
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	33	ACADL
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	9899	SV2B
R-HSA-167826	The fatty acid cycling model	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	7351	UCP2
R-HSA-8866423	VLDL biosynthesis	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	338	APOB
R-HSA-8865999	MET activates PTPN11	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	2549	GAB1
R-HSA-2161541	Abacavir metabolism	0.107367030835868	-2.23150211949145	5	1	0.00432900432900433	231	10287	5105	PCK1
R-HSA-977068	Termination of O-glycan biosynthesis	0.107550516115332	-2.22979462443908	25	2	0.00865800865800866	231	10287	256435,143662	ST6GALNAC3,MUC15
R-HSA-5654708	Downstream signaling of activated FGFR3	0.107550516115332	-2.22979462443908	25	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-70326	Glucose metabolism	0.108792847780294	-2.21830968403456	81	4	0.0173160173160173	231	10287	5224,5260,5105,8908	PGAM2,PHKG1,PCK1,GYG2
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.114858237881027	-2.16405662511389	26	2	0.00865800865800866	231	10287	6382,4958	SDC1,OMD
R-HSA-210991	Basigin interactions	0.114858237881027	-2.16405662511389	26	2	0.00865800865800866	231	10287	482,23539	ATP1B2,SLC16A8
R-HSA-5654716	Downstream signaling of activated FGFR4	0.122288654736509	-2.10137100644232	27	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	80319	CXXC4
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	6017	RLBP1
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	33	ACADL
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	22943	DKK1
R-HSA-6798163	Choline catabolism	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	1757	SARDH
R-HSA-3000484	Scavenging by Class F Receptors	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	338	APOB
R-HSA-6806942	MET Receptor Activation	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	3249	HPN
R-HSA-5690714	CD22 mediated BCR regulation	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	974	CD79B
R-HSA-111957	Cam-PDE 1 activation	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	5136	PDE1A
R-HSA-193144	Estrogen biosynthesis	0.127421321427694	-2.06025619170172	6	1	0.00432900432900433	231	10287	51171	HSD17B14
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.127746876714376	-2.05770449861695	86	4	0.0173160173160173	231	10287	2209,2214,122618,5295	FCGR1A,FCGR3A,PLD4,PIK3R1
R-HSA-5632684	Hedgehog 'on' state	0.127746876714376	-2.05770449861695	86	4	0.0173160173160173	231	10287	2619,3549,64399,2735	GAS1,IHH,HHIP,GLI1
R-HSA-70268	Pyruvate metabolism	0.129832633629537	-2.04150909160015	28	2	0.00865800865800866	231	10287	23539,5166	SLC16A8,PDK4
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.129832633629537	-2.04150909160015	28	2	0.00865800865800866	231	10287	775,2788	CACNA1C,GNG7
R-HSA-111933	Calmodulin induced events	0.129832633629537	-2.04150909160015	28	2	0.00865800865800866	231	10287	107,5136	ADCY1,PDE1A
R-HSA-211976	Endogenous sterols	0.129832633629537	-2.04150909160015	28	2	0.00865800865800866	231	10287	5740,51302	PTGIS,CYP39A1
R-HSA-111997	CaM pathway	0.129832633629537	-2.04150909160015	28	2	0.00865800865800866	231	10287	107,5136	ADCY1,PDE1A
R-HSA-5578775	Ion homeostasis	0.130827266087873	-2.03387740535373	56	3	0.012987012987013	231	10287	482,816,6546	ATP1B2,CAMK2B,SLC8A1
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.13169456206162	-2.02726996142994	87	4	0.0173160173160173	231	10287	2252,5295,3815,2549	FGF7,PIK3R1,KIT,GAB1
R-HSA-195721	Signaling by Wnt	0.13562509276342	-1.99786087071773	336	11	0.0476190476190476	231	10287	5593,80319,5330,8549,2788,22943,340419,55553,8325,144165,343637	PRKG2,CXXC4,PLCB2,LGR5,GNG7,DKK1,RSPO2,SOX6,FZD8,PRICKLE1,RSPO4
R-HSA-416482	G alpha (12/13) signalling events	0.135692243125593	-1.99736587570885	88	4	0.0173160173160173	231	10287	57449,84033,5295,2788	PLEKHG5,OBSCN,PIK3R1,GNG7
R-HSA-3000178	ECM proteoglycans	0.135941659123493	-1.99552946231619	57	3	0.012987012987013	231	10287	54829,4684,7143	ASPN,NCAM1,TNR
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.137481386604472	-1.98426674118817	29	2	0.00865800865800866	231	10287	816,2905	CAMK2B,GRIN2C
R-HSA-390918	Peroxisomal lipid metabolism	0.137481386604472	-1.98426674118817	29	2	0.00865800865800866	231	10287	11001,55825	SLC27A2,PECR
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.139686605408107	-1.96835389843202	122	5	0.0216450216450216	231	10287	10840,5740,5167,5169,54	ALDH1L1,PTGIS,ENPP1,ENPP3,ACP5
R-HSA-190236	Signaling by FGFR	0.13973890174105	-1.96797958519135	89	4	0.0173160173160173	231	10287	2549,80004,2252,5295	GAB1,ESRP2,FGF7,PIK3R1
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.141123898653341	-1.95811706059349	58	3	0.012987012987013	231	10287	2036,127833,2905	EPB41L1,SYT2,GRIN2C
R-HSA-416476	G alpha (q) signalling events	0.141334880380256	-1.95662316639148	192	7	0.0303030303030303	231	10287	2788,5295,2149,5330,2147,27334,886	GNG7,PIK3R1,F2R,PLCB2,F2,P2RY10,CCKAR
R-HSA-428157	Sphingolipid metabolism	0.143833505039661	-1.93909886334072	90	4	0.0173160173160173	231	10287	129807,151742,415,165679	NEU4,PPM1L,ARSE,SPTSSB
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.143833505039661	-1.93909886334072	90	4	0.0173160173160173	231	10287	2549,3815,2252,5295	GAB1,KIT,FGF7,PIK3R1
R-HSA-111996	Ca-dependent events	0.145226460008016	-1.92946096173341	30	2	0.00865800865800866	231	10287	107,5136	ADCY1,PDE1A
R-HSA-3656225	Defective CHST6 causes MCDC1	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	4958	OMD
R-HSA-433692	Proton-coupled monocarboxylate transport	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	23539	SLC16A8
R-HSA-5652084	Fructose metabolism	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	216	ALDH1A1
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	4958	OMD
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	2030	SLC29A1
R-HSA-6814848	Glycerophospholipid catabolism	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	375775	PNPLA7
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	107	ADCY1
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	4958	OMD
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.147026970173755	-1.9171392384623	7	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.153059724028929	-1.87692708062741	31	2	0.00865800865800866	231	10287	2875,374569	GPT,ASPG
R-HSA-352230	Amino acid transport across the plasma membrane	0.153059724028929	-1.87692708062741	31	2	0.00865800865800866	231	10287	55089,10991	SLC38A4,SLC38A3
R-HSA-5654687	Downstream signaling of activated FGFR1	0.153059724028929	-1.87692708062741	31	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-2129379	Molecules associated with elastic fibres	0.153059724028929	-1.87692708062741	31	2	0.00865800865800866	231	10287	8200,4237	GDF5,MFAP2
R-HSA-1296065	Inwardly rectifying K+ channels	0.153059724028929	-1.87692708062741	31	2	0.00865800865800866	231	10287	3764,2788	KCNJ8,GNG7
R-HSA-4086398	Ca2+ pathway	0.157053689701242	-1.85116755947376	61	3	0.012987012987013	231	10287	5593,2788,5330	PRKG2,GNG7,PLCB2
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.160670255612965	-1.8284011160091	94	4	0.0173160173160173	231	10287	5295,2252,3815,2549	PIK3R1,FGF7,KIT,GAB1
R-HSA-196071	Metabolism of steroid hormones	0.160973362515385	-1.82651637790107	32	2	0.00865800865800866	231	10287	147323,51171	STARD6,HSD17B14
R-HSA-70263	Gluconeogenesis	0.160973362515385	-1.82651637790107	32	2	0.00865800865800866	231	10287	5105,5224	PCK1,PGAM2
R-HSA-400451	Free fatty acids regulate insulin secretion	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	5330	PLCB2
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-73928	Depyrimidination	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-70921	Histidine catabolism	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	57571	CARNS1
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	2359	FPR3
R-HSA-1483148	Synthesis of PG	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	122618	PLD4
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	3549	IHH
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	5330	PLCB2
R-HSA-110329	Cleavage of the damaged pyrimidine	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	84894	LINGO1
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.166193971127644	-1.79459967202232	8	1	0.00432900432900433	231	10287	948	CD36
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.167968846165896	-1.78397675626362	63	3	0.012987012987013	231	10287	129807,256435,338596	NEU4,ST6GALNAC3,ST8SIA6
R-HSA-1226099	Signaling by FGFR in disease	0.167968846165896	-1.78397675626362	63	3	0.012987012987013	231	10287	5295,2252,2549	PIK3R1,FGF7,GAB1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.168959863084311	-1.77809408880837	33	2	0.00865800865800866	231	10287	2788,107	GNG7,ADCY1
R-HSA-1489509	DAG and IP3 signaling	0.177012007517196	-1.73153770962907	34	2	0.00865800865800866	231	10287	107,5136	ADCY1,PDE1A
R-HSA-913709	O-linked glycosylation of mucins	0.179098066789294	-1.71982176400335	65	3	0.012987012987013	231	10287	143662,256435,374907	MUC15,ST6GALNAC3,B3GNT8
R-HSA-2474795	Diseases associated with visual transduction	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	6017	RLBP1
R-HSA-166665	Terminal pathway of complement	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	730	C7
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	54763	ROPN1
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	760	CA2
R-HSA-193697	p75NTR regulates axonogenesis	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	84894	LINGO1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	8325	FZD8
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	2147	F2
R-HSA-2453864	Retinoid cycle disease events	0.184932096697367	-1.68776656616037	9	1	0.00432900432900433	231	10287	6017	RLBP1
R-HSA-4791275	Signaling by WNT in cancer	0.185122862459383	-1.68673555293277	35	2	0.00865800865800866	231	10287	22943,8325	DKK1,FZD8
R-HSA-167021	PLC-gamma1 signalling	0.193285770318327	-1.64358550997144	36	2	0.00865800865800866	231	10287	5136,107	PDE1A,ADCY1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.193285770318327	-1.64358550997144	36	2	0.00865800865800866	231	10287	5136,107	PDE1A,ADCY1
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.196152288602666	-1.62886393877972	68	3	0.012987012987013	231	10287	5740,66002,51302	PTGIS,CYP4F12,CYP39A1
R-HSA-5358351	Signaling by Hedgehog	0.198729639563188	-1.61580997314465	138	5	0.0216450216450216	231	10287	2735,64399,3549,2619,107	GLI1,HHIP,IHH,GAS1,ADCY1
R-HSA-419037	NCAM1 interactions	0.201494340501751	-1.60199398482979	37	2	0.00865800865800866	231	10287	775,4684	CACNA1C,NCAM1
R-HSA-6806834	Signaling by MET	0.201923909238903	-1.5998643394814	69	3	0.012987012987013	231	10287	3249,5295,2549	HPN,PIK3R1,GAB1
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	33	ACADL
R-HSA-419812	Calcitonin-like ligand receptors	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	10268	RAMP3
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-427601	Multifunctional anion exchangers	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	5172	SLC26A4
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-3229121	Glycogen storage diseases	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-196108	Pregnenolone biosynthesis	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	147323	STARD6
R-HSA-2562578	TRIF-mediated programmed cell death	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	929	CD14
R-HSA-170660	Adenylate cyclase activating pathway	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	107	ADCY1
R-HSA-2161522	Abacavir transport and metabolism	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	5105	PCK1
R-HSA-399997	Acetylcholine regulates insulin secretion	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	5330	PLCB2
R-HSA-425381	Bicarbonate transporters	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	6508	SLC4A3
R-HSA-1250342	PI3K events in ERBB4 signaling	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-5663084	Diseases of carbohydrate metabolism	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	2147	F2
R-HSA-190377	FGFR2b ligand binding and activation	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-430116	GP1b-IX-V activation signalling	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-8875656	MET receptor recycling	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	2549	GAB1
R-HSA-159740	Gamma-carboxylation of protein precursors	0.203250902463014	-1.59331409040164	10	1	0.00432900432900433	231	10287	2147	F2
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.20928546942037	-1.56405607659203	253	8	0.0346320346320346	231	10287	788,3158,33,1490,5244,7069,948,54511	SLC25A20,HMGCS2,ACADL,CCN2,ABCB4,THRSP,CD36,HMGCLL1
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.209742440850475	-1.56187497313775	38	2	0.00865800865800866	231	10287	2147,4352	F2,MPL
R-HSA-5655302	Signaling by FGFR1 in disease	0.209742440850475	-1.56187497313775	38	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-156590	Glutathione conjugation	0.209742440850475	-1.56187497313775	38	2	0.00865800865800866	231	10287	2953,2946	GSTT2,GSTM2
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.214984306458656	-1.53719024673416	106	4	0.0173160173160173	231	10287	6563,23539,55867,30061	SLC14A1,SLC16A8,SLC22A11,SLC40A1
R-HSA-1643685	Disease	0.216052512012701	-1.53223378967479	859	23	0.0995670995670996	231	10287	6017,22943,7057,6648,3714,6382,929,4958,9719,8325,2549,3815,2252,948,3549,143662,157869,8908,5295,9899,5608,127833,10417	RLBP1,DKK1,THBS1,SOD2,JAG2,SDC1,CD14,OMD,ADAMTSL2,FZD8,GAB1,KIT,FGF7,CD36,IHH,MUC15,SBSPON,GYG2,PIK3R1,SV2B,MAP2K6,SYT2,SPON2
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.218024189326319	-1.5231492621362	39	2	0.00865800865800866	231	10287	5295,974	PIK3R1,CD79B
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.218024189326319	-1.5231492621362	39	2	0.00865800865800866	231	10287	2147,415	F2,ARSE
R-HSA-194840	Rho GTPase cycle	0.218729720527046	-1.51991846420397	143	5	0.0216450216450216	231	10287	115703,1124,57449,57569,84033	ARHGAP33,CHN2,PLEKHG5,ARHGAP20,OBSCN
R-HSA-6794362	Protein-protein interactions at synapses	0.219467801986209	-1.51654974521658	72	3	0.012987012987013	231	10287	2905,127833,2036	GRIN2C,SYT2,EPB41L1
R-HSA-1980150	Signaling by NOTCH4	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-8875555	MET activates RAP1 and RAC1	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	2549	GAB1
R-HSA-71288	Creatine metabolism	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	2593	GAMT
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	51477	ISYNA1
R-HSA-1980148	Signaling by NOTCH3	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	5053	PAH
R-HSA-5625970	RHO GTPases activate KTN1	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	3798	KIF5A
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.221159732033741	-1.50887006915294	11	1	0.00432900432900433	231	10287	2147	F2
R-HSA-186797	Signaling by PDGF	0.225194031861619	-1.49079288457035	376	11	0.0476190476190476	231	10287	3815,2252,7057,816,107,2549,80310,4684,5136,5295,2905	KIT,FGF7,THBS1,CAMK2B,ADCY1,GAB1,PDGFD,NCAM1,PDE1A,PIK3R1,GRIN2C
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.226333946001516	-1.48574373316657	40	2	0.00865800865800866	231	10287	3815,10370	KIT,CITED2
R-HSA-5654741	Signaling by FGFR3	0.226333946001516	-1.48574373316657	40	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-991365	Activation of GABAB receptors	0.226333946001516	-1.48574373316657	40	2	0.00865800865800866	231	10287	2788,107	GNG7,ADCY1
R-HSA-977444	GABA B receptor activation	0.226333946001516	-1.48574373316657	40	2	0.00865800865800866	231	10287	2788,107	GNG7,ADCY1
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.226333946001516	-1.48574373316657	40	2	0.00865800865800866	231	10287	2030,53919	SLC29A1,SLCO1C1
R-HSA-5654743	Signaling by FGFR4	0.234666305173336	-1.44959075194792	41	2	0.00865800865800866	231	10287	5295,2549	PIK3R1,GAB1
R-HSA-879518	Transport of organic anions	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	53919	SLCO1C1
R-HSA-2022857	Keratan sulfate degradation	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	4958	OMD
R-HSA-1296346	Tandem pore domain potassium channels	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	89822	KCNK17
R-HSA-1475029	Reversible hydration of carbon dioxide	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	760	CA2
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	5593	PRKG2
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	10370	CITED2
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	83988	NCALD
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-417957	P2Y receptors	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	27334	P2RY10
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	83988	NCALD
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.238667721711797	-1.43268298011921	12	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-163685	Integration of energy metabolism	0.238965323472806	-1.43143682764915	111	4	0.0173160173160173	231	10287	2788,775,5330,107	GNG7,CACNA1C,PLCB2,ADCY1
R-HSA-3928662	EPHB-mediated forward signaling	0.243016087814104	-1.41462763283673	42	2	0.00865800865800866	231	10287	2051,2049	EPHB6,EPHB3
R-HSA-983189	Kinesins	0.243016087814104	-1.41462763283673	42	2	0.00865800865800866	231	10287	3798,113220	KIF5A,KIF12
R-HSA-1566948	Elastic fibre formation	0.243016087814104	-1.41462763283673	42	2	0.00865800865800866	231	10287	8200,4237	GDF5,MFAP2
R-HSA-3858494	Beta-catenin independent WNT signaling	0.243504871547963	-1.41261833030248	149	5	0.0216450216450216	231	10287	2788,5330,144165,8325,5593	GNG7,PLCB2,PRICKLE1,FZD8,PRKG2
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.251378334151081	-1.38079616732306	43	2	0.00865800865800866	231	10287	948,338	CD36,APOB
R-HSA-1236394	Signaling by ERBB4	0.251378334151081	-1.38079616732306	43	2	0.00865800865800866	231	10287	2670,5295	GFAP,PIK3R1
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.255390476405306	-1.36496162501667	78	3	0.012987012987013	231	10287	256435,338596,129807	ST6GALNAC3,ST8SIA6,NEU4
R-HSA-1663150	The activation of arylsulfatases	0.255783805043696	-1.36342270285141	13	1	0.00432900432900433	231	10287	415	ARSE
R-HSA-5210891	Uptake and function of anthrax toxins	0.255783805043696	-1.36342270285141	13	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	0.255783805043696	-1.36342270285141	13	1	0.00432900432900433	231	10287	10370	CITED2
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.255783805043696	-1.36342270285141	13	1	0.00432900432900433	231	10287	4137	MAPT
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.255783805043696	-1.36342270285141	13	1	0.00432900432900433	231	10287	760	CA2
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.255783805043696	-1.36342270285141	13	1	0.00432900432900433	231	10287	760	CA2
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.255783805043696	-1.36342270285141	13	1	0.00432900432900433	231	10287	10811	NOXA1
R-HSA-975634	Retinoid metabolism and transport	0.259748296527831	-1.34804220714623	44	2	0.00865800865800866	231	10287	6382,338	SDC1,APOB
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.259748296527831	-1.34804220714623	44	2	0.00865800865800866	231	10287	165679,151742	SPTSSB,PPM1L
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.259748296527831	-1.34804220714623	44	2	0.00865800865800866	231	10287	57571,5053	CARNS1,PAH
R-HSA-109704	PI3K Cascade	0.261461355879397	-1.34146878506138	79	3	0.012987012987013	231	10287	2549,5295,2252	GAB1,PIK3R1,FGF7
R-HSA-422356	Regulation of insulin secretion	0.267550802889751	-1.31844581333323	80	3	0.012987012987013	231	10287	5330,2788,775	PLCB2,GNG7,CACNA1C
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.268121432444623	-1.31631529495622	45	2	0.00865800865800866	231	10287	6382,7057	SDC1,THBS1
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.272516717351789	-1.3000553186806	14	1	0.00432900432900433	231	10287	6546	SLC8A1
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.272516717351789	-1.3000553186806	14	1	0.00432900432900433	231	10287	5166	PDK4
R-HSA-1483213	Synthesis of PE	0.272516717351789	-1.3000553186806	14	1	0.00432900432900433	231	10287	162466	PHOSPHO1
R-HSA-1660662	Glycosphingolipid metabolism	0.276493397814104	-1.2855683360115	46	2	0.00865800865800866	231	10287	415,129807	ARSE,NEU4
R-HSA-2424491	DAP12 signaling	0.27892661108805	-1.27680657445773	356	10	0.0432900432900433	231	10287	107,2549,4684,2905,5295,5136,54209,3815,816,2252	ADCY1,GAB1,NCAM1,GRIN2C,PIK3R1,PDE1A,TREM2,KIT,CAMK2B,FGF7
R-HSA-201681	TCF dependent signaling in response to WNT	0.287294517170528	-1.24724739716602	238	7	0.0303030303030303	231	10287	22943,340419,343637,8549,8325,55553,80319	DKK1,RSPO2,RSPO4,LGR5,FZD8,SOX6,CXXC4
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	107	ADCY1
R-HSA-211935	Fatty acids	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	66002	CYP4F12
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	107	ADCY1
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	5740	PTGIS
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	22943	DKK1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	5740	PTGIS
R-HSA-975577	N-Glycan antennae elongation	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	338596	ST8SIA6
R-HSA-3322077	Glycogen synthesis	0.288875000065825	-1.24176121015972	15	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.293191898905562	-1.22692793927781	443	12	0.051948051948052	231	10287	5330,2252,816,2788,3815,886,2147,2149,5295,2905,4684,27334	PLCB2,FGF7,CAMK2B,GNG7,KIT,CCKAR,F2,F2R,PIK3R1,GRIN2C,NCAM1,P2RY10
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.293217393393931	-1.2268409881032	48	2	0.00865800865800866	231	10287	2788,5295	GNG7,PIK3R1
R-HSA-418597	G alpha (z) signalling events	0.293217393393931	-1.2268409881032	48	2	0.00865800865800866	231	10287	107,2788	ADCY1,GNG7
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.298526662202786	-1.20889602952598	322	9	0.038961038961039	231	10287	7504,886,2147,6755,2149,4987,51554,2359,27334	XK,CCKAR,F2,SSTR5,F2R,OPRL1,ACKR4,FPR3,P2RY10
R-HSA-76002	Platelet activation, signaling and aggregation	0.300400386265587	-1.20263907325548	282	8	0.0346320346320346	231	10287	2162,5295,2149,2147,948,2788,4352,7057	F13A1,PIK3R1,F2R,F2,CD36,GNG7,MPL,THBS1
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.301561669394447	-1.19878074179228	49	2	0.00865800865800866	231	10287	5166,23539	PDK4,SLC16A8
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.303727683894645	-1.19162375568594	124	4	0.0173160173160173	231	10287	2209,54209,2214,4068	FCGR1A,TREM2,FCGR3A,SH2D1A
R-HSA-1989781	PPARA activates gene expression	0.303727683894645	-1.19162375568594	124	4	0.0173160173160173	231	10287	5244,1490,3158,948	ABCB4,CCN2,HMGCS2,CD36
R-HSA-163615	PKA activation	0.304867005020636	-1.18787964658446	16	1	0.00432900432900433	231	10287	107	ADCY1
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.304867005020636	-1.18787964658446	16	1	0.00432900432900433	231	10287	3815	KIT
R-HSA-1433559	Regulation of KIT signaling	0.304867005020636	-1.18787964658446	16	1	0.00432900432900433	231	10287	3815	KIT
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.304867005020636	-1.18787964658446	16	1	0.00432900432900433	231	10287	929	CD14
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.304867005020636	-1.18787964658446	16	1	0.00432900432900433	231	10287	27334	P2RY10
R-HSA-549132	Organic cation/anion/zwitterion transport	0.304867005020636	-1.18787964658446	16	1	0.00432900432900433	231	10287	55867	SLC22A11
R-HSA-1257604	PIP3 activates AKT signaling	0.308806051043446	-1.17504186567555	125	4	0.0173160173160173	231	10287	2549,3815,5295,2252	GAB1,KIT,PIK3R1,FGF7
R-HSA-5654736	Signaling by FGFR1	0.309889254257559	-1.17154028966036	50	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-1227986	Signaling by ERBB2	0.318196701374281	-1.14508552964921	51	2	0.00865800865800866	231	10287	2549,5295	GAB1,PIK3R1
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.318987735772806	-1.14260262278963	127	4	0.0173160173160173	231	10287	3158,948,1490,5244	HMGCS2,CD36,CCN2,ABCB4
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	107	ADCY1
R-HSA-164378	PKA activation in glucagon signalling	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	107	ADCY1
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	929	CD14
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	143662	MUC15
R-HSA-140534	Ligand-dependent caspase activation	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	929	CD14
R-HSA-2033519	Activated point mutants of FGFR2	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-5627117	RHO GTPases Activate ROCKs	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	10398	MYL9
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	143662	MUC15
R-HSA-432142	Platelet sensitization by LDL	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	338	APOB
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	9256	TSPOAP1
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	2891	GRIA2
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	143662	MUC15
R-HSA-5625900	RHO GTPases activate CIT	0.320500898698783	-1.13787019857298	17	1	0.00432900432900433	231	10287	10398	MYL9
R-HSA-1483257	Phospholipid metabolism	0.321210528429274	-1.13565851902433	207	6	0.025974025974026	231	10287	117245,5295,122618,162466,375775,1757	PLAAT5,PIK3R1,PLD4,PHOSPHO1,PNPLA7,SARDH
R-HSA-2172127	DAP12 interactions	0.3225381799563	-1.13153376229216	371	10	0.0432900432900433	231	10287	54209,3815,816,2252,107,2549,4684,5295,2905,5136	TREM2,KIT,CAMK2B,FGF7,ADCY1,GAB1,NCAM1,PIK3R1,GRIN2C,PDE1A
R-HSA-198203	PI3K/AKT activation	0.32408908270844	-1.12673685434972	128	4	0.0173160173160173	231	10287	2549,5295,2252,3815	GAB1,PIK3R1,FGF7,KIT
R-HSA-180292	GAB1 signalosome	0.32408908270844	-1.12673685434972	128	4	0.0173160173160173	231	10287	3815,5295,2252,2549	KIT,PIK3R1,FGF7,GAB1
R-HSA-1483206	Glycerophospholipid biosynthesis	0.329196138078325	-1.11110154148034	129	4	0.0173160173160173	231	10287	117245,122618,162466,1757	PLAAT5,PLD4,PHOSPHO1,SARDH
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.334738199651898	-1.09440654625879	53	2	0.00865800865800866	231	10287	338,6382	APOB,SDC1
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-197264	Nicotinamide salvaging	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	5740	PTGIS
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	929	CD14
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	225	ABCD2
R-HSA-912631	Regulation of signaling by CBL	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	9256	TSPOAP1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	9256	TSPOAP1
R-HSA-196757	Metabolism of folate and pterines	0.335784666208285	-1.0912851988468	18	1	0.00432900432900433	231	10287	10840	ALDH1L1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.339423561692602	-1.08050650698698	131	4	0.0173160173160173	231	10287	2252,5295,3815,2549	FGF7,PIK3R1,KIT,GAB1
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.350726115429748	-1.0477496580281	19	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.350726115429748	-1.0477496580281	19	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.350726115429748	-1.0477496580281	19	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-416700	Other semaphorin interactions	0.350726115429748	-1.0477496580281	19	1	0.00432900432900433	231	10287	54209	TREM2
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.350726115429748	-1.0477496580281	19	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-877300	Interferon gamma signaling	0.353729099964903	-1.03922391314136	94	3	0.012987012987013	231	10287	4684,816,2209	NCAM1,CAMK2B,FCGR1A
R-HSA-977443	GABA receptor activation	0.359322266713138	-1.02353561429989	56	2	0.00865800865800866	231	10287	107,2788	ADCY1,GNG7
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.35988367978716	-1.02197441144615	95	3	0.012987012987013	231	10287	5608,948,929	MAP2K6,CD36,CD14
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.35988367978716	-1.02197441144615	95	3	0.012987012987013	231	10287	929,5608,948	CD14,MAP2K6,CD36
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.35988367978716	-1.02197441144615	95	3	0.012987012987013	231	10287	929,948,5608	CD14,CD36,MAP2K6
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.35988367978716	-1.02197441144615	95	3	0.012987012987013	231	10287	5608,948,929	MAP2K6,CD36,CD14
R-HSA-194315	Signaling by Rho GTPases	0.363854280257149	-1.01100182046231	427	11	0.0476190476190476	231	10287	4638,10398,57449,57569,84033,1124,115703,10811,3798,401541,54763	MYLK,MYL9,PLEKHG5,ARHGAP20,OBSCN,CHN2,ARHGAP33,NOXA1,KIF5A,CENPP,ROPN1
R-HSA-190241	FGFR2 ligand binding and activation	0.365332880858667	-1.0069463386686	20	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.365332880858667	-1.0069463386686	20	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.365332880858667	-1.0069463386686	20	1	0.00432900432900433	231	10287	1271	CNTFR
R-HSA-193704	p75 NTR receptor-mediated signalling	0.372166606278994	-0.988413658629805	97	3	0.012987012987013	231	10287	84033,84894,57449	OBSCN,LINGO1,PLEKHG5
R-HSA-3000480	Scavenging by Class A Receptors	0.379612427415421	-0.968604474596207	21	1	0.00432900432900433	231	10287	338	APOB
R-HSA-2024096	HS-GAG degradation	0.379612427415421	-0.968604474596207	21	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-8849932	SALM protein interactions at the synapses	0.379612427415421	-0.968604474596207	21	1	0.00432900432900433	231	10287	2905	GRIN2C
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.379612427415421	-0.968604474596207	21	1	0.00432900432900433	231	10287	2147	F2
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.379612427415421	-0.968604474596207	21	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-445144	Signal transduction by L1	0.379612427415421	-0.968604474596207	21	1	0.00432900432900433	231	10287	4684	NCAM1
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.384405548521951	-0.956057167749924	99	3	0.012987012987013	231	10287	90019,338,127833	SYT8,APOB,SYT2
R-HSA-166520	Signalling by NGF	0.384992957410731	-0.954530237301322	477	12	0.051948051948052	231	10287	2549,107,5295,2905,5136,4684,57449,816,84033,2252,84894,3815	GAB1,ADCY1,PIK3R1,GRIN2C,PDE1A,NCAM1,PLEKHG5,CAMK2B,OBSCN,FGF7,LINGO1,KIT
R-HSA-193648	NRAGE signals death through JNK	0.391564762729635	-0.937604355189506	60	2	0.00865800865800866	231	10287	57449,84033	PLEKHG5,OBSCN
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.393572054257814	-0.932491116685928	22	1	0.00432900432900433	231	10287	2147	F2
R-HSA-373753	Nephrin interactions	0.393572054257814	-0.932491116685928	22	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.393572054257814	-0.932491116685928	22	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-202131	Metabolism of nitric oxide	0.393572054257814	-0.932491116685928	22	1	0.00432900432900433	231	10287	5593	PRKG2
R-HSA-203765	eNOS activation and regulation	0.393572054257814	-0.932491116685928	22	1	0.00432900432900433	231	10287	5593	PRKG2
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.393572054257814	-0.932491116685928	22	1	0.00432900432900433	231	10287	33	ACADL
R-HSA-186763	Downstream signal transduction	0.393638251197319	-0.932322935605975	352	9	0.038961038961039	231	10287	2252,816,3815,5136,5295,2905,4684,2549,107	FGF7,CAMK2B,KIT,PDE1A,PIK3R1,GRIN2C,NCAM1,GAB1,ADCY1
R-HSA-2187338	Visual phototransduction	0.396590186633175	-0.924851806941416	101	3	0.012987012987013	231	10287	6017,6382,338	RLBP1,SDC1,APOB
R-HSA-1236975	Antigen processing-Cross presentation	0.396590186633175	-0.924851806941416	101	3	0.012987012987013	231	10287	2209,948,929	FCGR1A,CD36,CD14
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.399514290633711	-0.917505743117185	61	2	0.00865800865800866	231	10287	2209,2214	FCGR1A,FCGR3A
R-HSA-8853659	RET signaling	0.404001873263557	-0.906335764240755	270	7	0.0303030303030303	231	10287	816,2905,5295,2252,3815,4684,2549	CAMK2B,GRIN2C,PIK3R1,FGF7,KIT,NCAM1,GAB1
R-HSA-8855121	VLDL interactions	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	338	APOB
R-HSA-389948	PD-1 signaling	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	5133	PDCD1
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	9256	TSPOAP1
R-HSA-428930	Thromboxane signalling through TP receptor	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	6017	RLBP1
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-3371571	HSF1-dependent transactivation	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	816	CAMK2B
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	6648	SOD2
R-HSA-8863678	Neurodegenerative Diseases	0.407218898445431	-0.898404404102162	23	1	0.00432900432900433	231	10287	6648	SOD2
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.42055993842814	-0.866168268875415	24	1	0.00432900432900433	231	10287	929	CD14
R-HSA-171052	LDL-mediated lipid transport	0.42055993842814	-0.866168268875415	24	1	0.00432900432900433	231	10287	338	APOB
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.42055993842814	-0.866168268875415	24	1	0.00432900432900433	231	10287	9256	TSPOAP1
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.42055993842814	-0.866168268875415	24	1	0.00432900432900433	231	10287	10398	MYL9
R-HSA-177929	Signaling by EGFR	0.432343467452774	-0.838534943085535	364	9	0.038961038961039	231	10287	2549,107,5136,5295,2905,4684,2252,816,3815	GAB1,ADCY1,PDE1A,PIK3R1,GRIN2C,NCAM1,FGF7,CAMK2B,KIT
R-HSA-3295583	TRP channels	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	55283	MCOLN3
R-HSA-1296041	Activation of G protein gated Potassium channels	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-425410	Metal ion SLC transporters	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	30061	SLC40A1
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-982772	Growth hormone receptor signaling	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	1154	CISH
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	26289	AK5
R-HSA-1251985	Nuclear signaling by ERBB4	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	2670	GFAP
R-HSA-1296059	G protein gated Potassium channels	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.43360199769082	-0.835628221646789	25	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-4608870	Asymmetric localization of PCP proteins	0.446132549819128	-0.807139174212451	67	2	0.00865800865800866	231	10287	8325,144165	FZD8,PRICKLE1
R-HSA-975298	Ligand-gated ion channel transport	0.44635174808228	-0.806647964970843	26	1	0.00432900432900433	231	10287	8001	GLRA3
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.44635174808228	-0.806647964970843	26	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.44635174808228	-0.806647964970843	26	1	0.00432900432900433	231	10287	338596	ST8SIA6
R-HSA-8856688	Golgi-to-ER retrograde transport	0.450499734761183	-0.797397790699327	110	3	0.012987012987013	231	10287	3798,5050,113220	KIF5A,PAFAH1B3,KIF12
R-HSA-168898	Toll-Like Receptors Cascades	0.451185168023347	-0.795877451627275	153	4	0.0173160173160173	231	10287	929,5608,338,948	CD14,MAP2K6,APOB,CD36
R-HSA-5663202	Diseases of signal transduction	0.451648768156052	-0.794850462820422	370	9	0.038961038961039	231	10287	3714,5295,8325,2549,6017,22943,3815,2252,3549	JAG2,PIK3R1,FZD8,GAB1,RLBP1,DKK1,KIT,FGF7,IHH
R-HSA-373755	Semaphorin interactions	0.45370770926199	-0.790302100475117	68	2	0.00865800865800866	231	10287	54209,10398	TREM2,MYL9
R-HSA-1474228	Degradation of the extracellular matrix	0.456375690640775	-0.784438925688883	111	3	0.012987012987013	231	10287	50859,827,11131	SPOCK3,CAPN6,CAPN11
R-HSA-1266738	Developmental Biology	0.45792594235728	-0.781047805852337	1075	25	0.108225108225108	231	10287	54209,10398,816,2042,2549,6326,288,6329,3851,6327,11005,2049,5105,948,2252,2051,3815,5608,6768,2905,55740,5295,4684,2044,775	TREM2,MYL9,CAMK2B,EPHA3,GAB1,SCN2A,ANK3,SCN4A,KRT4,SCN2B,SPINK5,EPHB3,PCK1,CD36,FGF7,EPHB6,KIT,MAP2K6,ST14,GRIN2C,ENAH,PIK3R1,NCAM1,EPHA5,CACNA1C
R-HSA-6783589	Interleukin-6 family signaling	0.45881571321408	-0.779106645808418	27	1	0.00432900432900433	231	10287	1271	CNTFR
R-HSA-977606	Regulation of Complement cascade	0.45881571321408	-0.779106645808418	27	1	0.00432900432900433	231	10287	730	C7
R-HSA-400685	Sema4D in semaphorin signaling	0.45881571321408	-0.779106645808418	27	1	0.00432900432900433	231	10287	10398	MYL9
R-HSA-180024	DARPP-32 events	0.45881571321408	-0.779106645808418	27	1	0.00432900432900433	231	10287	84152	PPP1R1B
R-HSA-388841	Costimulation by the CD28 family	0.461223643579407	-0.773872226551284	69	2	0.00865800865800866	231	10287	5295,5133	PIK3R1,PDCD1
R-HSA-372790	Signaling by GPCR	0.464164920231155	-0.767515358374043	1299	30	0.12987012987013	231	10287	80835,3815,2252,7504,84152,27115,3549,4684,10268,2905,4987,5295,2149,107,2788,8622,5330,816,84033,56656,57449,2147,5745,886,51554,5136,6755,8325,2359,27334	TAS1R1,KIT,FGF7,XK,PPP1R1B,PDE7B,IHH,NCAM1,RAMP3,GRIN2C,OPRL1,PIK3R1,F2R,ADCY1,GNG7,PDE8B,PLCB2,CAMK2B,OBSCN,OR2S2,PLEKHG5,F2,PTH1R,CCKAR,ACKR4,PDE1A,SSTR5,FZD8,FPR3,P2RY10
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.466059304107117	-0.763442390921178	156	4	0.0173160173160173	231	10287	3798,2625,4778,113220	KIF5A,GATA3,NFE2,KIF12
R-HSA-1483191	Synthesis of PC	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	162466	PHOSPHO1
R-HSA-2022854	Keratan sulfate biosynthesis	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	4958	OMD
R-HSA-174800	Chylomicron-mediated lipid transport	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	338	APOB
R-HSA-1266695	Interleukin-7 signaling	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	929	CD14
R-HSA-5576893	Phase 2 - plateau phase	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	775	CACNA1C
R-HSA-5621480	Dectin-2 family	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	143662	MUC15
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	5050	PAFAH1B3
R-HSA-6803529	FGFR2 alternative splicing	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	80004	ESRP2
R-HSA-264876	Insulin processing	0.471000271723225	-0.752896608058827	28	1	0.00432900432900433	231	10287	3798	KIF5A
R-HSA-6809371	Formation of the cornified envelope	0.476073253036669	-0.742183543656842	71	2	0.00865800865800866	231	10287	6768,11005	ST14,SPINK5
R-HSA-73923	Lipid digestion, mobilization, and transport	0.479608619460006	-0.73478488380511	115	3	0.012987012987013	231	10287	29881,338,1149	NPC1L1,APOB,CIDEA
R-HSA-166054	Activated TLR4 signalling	0.479608619460006	-0.73478488380511	115	3	0.012987012987013	231	10287	929,5608,948	CD14,MAP2K6,CD36
R-HSA-525793	Myogenesis	0.482911660465156	-0.727921539645036	29	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-196807	Nicotinate metabolism	0.482911660465156	-0.727921539645036	29	1	0.00432900432900433	231	10287	5740	PTGIS
R-HSA-1482839	Acyl chain remodelling of PE	0.482911660465156	-0.727921539645036	29	1	0.00432900432900433	231	10287	117245	PLAAT5
R-HSA-375170	CDO in myogenesis	0.482911660465156	-0.727921539645036	29	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-202040	G-protein activation	0.482911660465156	-0.727921539645036	29	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.482911660465156	-0.727921539645036	29	1	0.00432900432900433	231	10287	1490	CCN2
R-HSA-112399	IRS-mediated signalling	0.491854370975368	-0.70957260025719	294	7	0.0303030303030303	231	10287	2549,4684,3815,816,2905,5295,2252	GAB1,NCAM1,KIT,CAMK2B,GRIN2C,PIK3R1,FGF7
R-HSA-420092	Glucagon-type ligand receptors	0.494555977717169	-0.704094933684686	30	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.494555977717169	-0.704094933684686	30	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-71387	Metabolism of carbohydrates	0.499034527059937	-0.695079993119426	296	7	0.0303030303030303	231	10287	216,4958,8908,6382,5224,5105,5260	ALDH1A1,OMD,GYG2,SDC1,PGAM2,PCK1,PHKG1
R-HSA-74751	Insulin receptor signalling cascade	0.502612922112909	-0.687934943672099	297	7	0.0303030303030303	231	10287	2549,2252,5295,2905,816,4684,3815	GAB1,FGF7,PIK3R1,GRIN2C,CAMK2B,NCAM1,KIT
R-HSA-948021	Transport to the Golgi and subsequent modification	0.504979406984611	-0.683237628786528	164	4	0.0173160173160173	231	10287	338596,288,57134,79090	ST8SIA6,ANK3,MAN1C1,TRAPPC6A
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.505720917523583	-0.681770308248416	387	9	0.038961038961039	231	10287	4684,5136,2905,5295,107,2549,3815,2252,816	NCAM1,PDE1A,GRIN2C,PIK3R1,ADCY1,GAB1,KIT,FGF7,CAMK2B
R-HSA-1839124	FGFR1 mutant receptor activation	0.5059391861764	-0.681338802339652	31	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-2022928	HS-GAG biosynthesis	0.5059391861764	-0.681338802339652	31	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-8875878	MET promotes cell motility	0.5059391861764	-0.681338802339652	31	1	0.00432900432900433	231	10287	2549	GAB1
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.5059391861764	-0.681338802339652	31	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-2428928	IRS-related events triggered by IGF1R	0.506183207879884	-0.680856604317664	298	7	0.0303030303030303	231	10287	5295,816,2905,2252,4684,3815,2549	PIK3R1,CAMK2B,GRIN2C,FGF7,NCAM1,KIT,GAB1
R-HSA-2428924	IGF1R signaling cascade	0.506183207879884	-0.680856604317664	298	7	0.0303030303030303	231	10287	2549,3815,4684,816,5295,2905,2252	GAB1,KIT,NCAM1,CAMK2B,PIK3R1,GRIN2C,FGF7
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.509745148089066	-0.673844387789515	299	7	0.0303030303030303	231	10287	2549,4684,3815,2905,5295,816,2252	GAB1,NCAM1,KIT,GRIN2C,PIK3R1,CAMK2B,FGF7
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.512088818715405	-0.669257194933987	76	2	0.00865800865800866	231	10287	84033,57449	OBSCN,PLEKHG5
R-HSA-912526	Interleukin receptor SHC signaling	0.5122712877707	-0.668900935341156	255	6	0.025974025974026	231	10287	2905,816,5295,2252,3815,4684	GRIN2C,CAMK2B,PIK3R1,FGF7,KIT,NCAM1
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.517067115979462	-0.65958259475726	32	1	0.00432900432900433	231	10287	50859	SPOCK3
R-HSA-376176	Signaling by Robo receptor	0.517067115979462	-0.65958259475726	32	1	0.00432900432900433	231	10287	55740	ENAH
R-HSA-168638	NOD1/2 Signaling Pathway	0.517067115979462	-0.65958259475726	32	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-70171	Glycolysis	0.517067115979462	-0.65958259475726	32	1	0.00432900432900433	231	10287	5224	PGAM2
R-HSA-449147	Signaling by Interleukins	0.517496544133752	-0.658752431867322	525	12	0.051948051948052	231	10287	5608,2162,6097,5295,2905,2625,4684,1271,948,816,2252,3815	MAP2K6,F13A1,RORC,PIK3R1,GRIN2C,GATA3,NCAM1,CNTFR,CD36,CAMK2B,FGF7,KIT
R-HSA-202433	Generation of second messenger molecules	0.527945467643849	-0.638762281587282	33	1	0.00432900432900433	231	10287	55740	ENAH
R-HSA-1839126	FGFR2 mutant receptor activation	0.527945467643849	-0.638762281587282	33	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-1980145	Signaling by NOTCH2	0.527945467643849	-0.638762281587282	33	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-392518	Signal amplification	0.527945467643849	-0.638762281587282	33	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.527945467643849	-0.638762281587282	33	1	0.00432900432900433	231	10287	4958	OMD
R-HSA-389356	CD28 co-stimulation	0.527945467643849	-0.638762281587282	33	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-1483255	PI Metabolism	0.532907098933907	-0.629408168443477	79	2	0.00865800865800866	231	10287	375775,5295	PNPLA7,PIK3R1
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.538579814907048	-0.61881957627118	34	1	0.00432900432900433	231	10287	2252	FGF7
R-HSA-451927	Interleukin-2 signaling	0.538889395484134	-0.618244932313618	262	6	0.025974025974026	231	10287	3815,4684,5295,816,2905,2252	KIT,NCAM1,PIK3R1,CAMK2B,GRIN2C,FGF7
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.540941075711385	-0.614444923421769	126	3	0.012987012987013	231	10287	929,5608,948	CD14,MAP2K6,CD36
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.553113381115837	-0.592192269332842	82	2	0.00865800865800866	231	10287	113220,3798	KIF12,KIF5A
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.569072725354224	-0.563747040449809	37	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-73884	Base Excision Repair	0.569072725354224	-0.563747040449809	37	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.572174197556576	-0.558311792782768	271	6	0.025974025974026	231	10287	2252,2905,816,5295,3815,4684	FGF7,GRIN2C,CAMK2B,PIK3R1,KIT,NCAM1
R-HSA-114608	Platelet degranulation	0.572604207091274	-0.557560538997447	132	3	0.012987012987013	231	10287	7057,2162,948	THBS1,F13A1,CD36
R-HSA-1236974	ER-Phagosome pathway	0.572697669845196	-0.557397328308612	85	2	0.00865800865800866	231	10287	929,948	CD14,CD36
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.574312809763715	-0.554581066356783	179	4	0.0173160173160173	231	10287	3798,57134,5050,113220	KIF5A,MAN1C1,PAFAH1B3,KIF12
R-HSA-69236	G1 Phase	0.588278043225412	-0.53055558021956	39	1	0.00432900432900433	231	10287	1028	CDKN1C
R-HSA-69231	Cyclin D associated events in G1	0.588278043225412	-0.53055558021956	39	1	0.00432900432900433	231	10287	1028	CDKN1C
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.588278043225412	-0.53055558021956	39	1	0.00432900432900433	231	10287	4137	MAPT
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.588278043225412	-0.53055558021956	39	1	0.00432900432900433	231	10287	80835	TAS1R1
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.588497807360639	-0.530182078099046	229	5	0.0216450216450216	231	10287	3815,2252,5295,974,2549	KIT,FGF7,PIK3R1,CD79B,GAB1
R-HSA-74752	Signaling by Insulin receptor	0.588874476186573	-0.529542231477805	322	7	0.0303030303030303	231	10287	2549,3815,4684,2252,5295,2905,816	GAB1,KIT,NCAM1,FGF7,PIK3R1,GRIN2C,CAMK2B
R-HSA-375165	NCAM signaling for neurite out-growth	0.590154706792528	-0.527370561552101	276	6	0.025974025974026	231	10287	2905,816,2252,4684,3815,775	GRIN2C,CAMK2B,FGF7,NCAM1,KIT,CACNA1C
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.591653920586743	-0.524833408643071	88	2	0.00865800865800866	231	10287	5105,948	PCK1,CD36
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.597937981869671	-0.514268239657722	137	3	0.012987012987013	231	10287	7057,948,2162	THBS1,CD36,F13A1
R-HSA-8856828	Clathrin-mediated endocytosis	0.597937981869671	-0.514268239657722	137	3	0.012987012987013	231	10287	90019,338,127833	SYT8,APOB,SYT2
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.609979566850216	-0.494329819342675	91	2	0.00865800865800866	231	10287	5608,929	MAP2K6,CD14
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.615499625670636	-0.485320941528999	42	1	0.00432900432900433	231	10287	57604	TRMT9B
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.615499625670636	-0.485320941528999	42	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-446203	Asparagine N-linked glycosylation	0.618092283202537	-0.481117507101952	284	6	0.025974025974026	231	10287	288,338596,256435,79090,129807,57134	ANK3,ST8SIA6,ST6GALNAC3,TRAPPC6A,NEU4,MAN1C1
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.621846453487351	-0.475062076062836	93	2	0.00865800865800866	231	10287	5608,929	MAP2K6,CD14
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.621846453487351	-0.475062076062836	93	2	0.00865800865800866	231	10287	929,5608	CD14,MAP2K6
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.624169180224135	-0.471333825205616	43	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.624169180224135	-0.471333825205616	43	1	0.00432900432900433	231	10287	55553	SOX6
R-HSA-917937	Iron uptake and transport	0.632644084491276	-0.457847282756065	44	1	0.00432900432900433	231	10287	30061	SLC40A1
R-HSA-5668914	Diseases of metabolism	0.632644084491276	-0.457847282756065	44	1	0.00432900432900433	231	10287	8908	GYG2
R-HSA-1433557	Signaling by SCF-KIT	0.636929796369393	-0.45109583926469	337	7	0.0303030303030303	231	10287	2252,2905,5295,816,3815,4684,2549	FGF7,GRIN2C,PIK3R1,CAMK2B,KIT,NCAM1,GAB1
R-HSA-418594	G alpha (i) signalling events	0.637424445866162	-0.45031952526154	242	5	0.0216450216450216	231	10287	4987,6755,2788,107,2359	OPRL1,SSTR5,GNG7,ADCY1,FPR3
R-HSA-4086400	PCP/CE pathway	0.639123495035606	-0.447657580310964	96	2	0.00865800865800866	231	10287	8325,144165	FZD8,PRICKLE1
R-HSA-6811438	Intra-Golgi traffic	0.640928690225794	-0.444837075947621	45	1	0.00432900432900433	231	10287	57134	MAN1C1
R-HSA-166658	Complement cascade	0.640928690225794	-0.444837075947621	45	1	0.00432900432900433	231	10287	730	C7
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.644743640067899	-0.438902498452508	97	2	0.00865800865800866	231	10287	929,5608	CD14,MAP2K6
R-HSA-180336	SHC1 events in EGFR signaling	0.648197374675915	-0.433560038458896	245	5	0.0216450216450216	231	10287	4684,3815,2905,816,2252	NCAM1,KIT,GRIN2C,CAMK2B,FGF7
R-HSA-5673001	RAF/MAP kinase cascade	0.648197374675915	-0.433560038458896	245	5	0.0216450216450216	231	10287	2252,2905,816,3815,4684	FGF7,GRIN2C,CAMK2B,KIT,NCAM1
R-HSA-179812	GRB2 events in EGFR signaling	0.648197374675915	-0.433560038458896	245	5	0.0216450216450216	231	10287	2252,816,2905,4684,3815	FGF7,CAMK2B,GRIN2C,NCAM1,KIT
R-HSA-112412	SOS-mediated signalling	0.648197374675915	-0.433560038458896	245	5	0.0216450216450216	231	10287	4684,3815,816,2905,2252	NCAM1,KIT,CAMK2B,GRIN2C,FGF7
R-HSA-446652	Interleukin-1 signaling	0.649027252280958	-0.432280571971736	46	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.649841034589935	-0.431027508171989	197	4	0.0173160173160173	231	10287	2549,3815,5295,2252	GAB1,KIT,PIK3R1,FGF7
R-HSA-195258	RHO GTPase Effectors	0.651471066101836	-0.428522294605538	294	6	0.025974025974026	231	10287	10398,4638,54763,3798,401541,10811	MYL9,MYLK,ROPN1,KIF5A,CENPP,NOXA1
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.65577696181443	-0.421934545084312	99	2	0.00865800865800866	231	10287	5608,929	MAP2K6,CD14
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.65577696181443	-0.421934545084312	99	2	0.00865800865800866	231	10287	929,5608	CD14,MAP2K6
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.65577696181443	-0.421934545084312	99	2	0.00865800865800866	231	10287	5608,929	MAP2K6,CD14
R-HSA-8948216	Collagen chain trimerization	0.656943930805377	-0.420156605379211	47	1	0.00432900432900433	231	10287	81578	COL21A1
R-HSA-170984	ARMS-mediated activation	0.662247021087681	-0.412116649008922	249	5	0.0216450216450216	231	10287	2252,816,2905,3815,4684	FGF7,CAMK2B,GRIN2C,KIT,NCAM1
R-HSA-187706	Signalling to p38 via RIT and RIN	0.662247021087681	-0.412116649008922	249	5	0.0216450216450216	231	10287	2252,816,2905,3815,4684	FGF7,CAMK2B,GRIN2C,KIT,NCAM1
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.664682793296533	-0.4084453546898	48	1	0.00432900432900433	231	10287	1628	DBP
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.664682793296533	-0.4084453546898	48	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-380108	Chemokine receptors bind chemokines	0.664682793296533	-0.4084453546898	48	1	0.00432900432900433	231	10287	51554	ACKR4
R-HSA-913531	Interferon Signaling	0.6653703289511	-0.407411507688796	201	4	0.0173160173160173	231	10287	4684,816,2317,2209	NCAM1,CAMK2B,FLNB,FCGR1A
R-HSA-170968	Frs2-mediated activation	0.665702652682425	-0.406912175581818	250	5	0.0216450216450216	231	10287	2252,816,2905,3815,4684	FGF7,CAMK2B,GRIN2C,KIT,NCAM1
R-HSA-5610787	Hedgehog 'off' state	0.66653613394051	-0.405660926368544	101	2	0.00865800865800866	231	10287	107,2735	ADCY1,GLI1
R-HSA-5684996	MAPK1/MAPK3 signaling	0.669135398837606	-0.401768849440192	251	5	0.0216450216450216	231	10287	3815,4684,2252,816,2905	KIT,NCAM1,FGF7,CAMK2B,GRIN2C
R-HSA-169893	Prolonged ERK activation events	0.672545182391506	-0.396685984050725	252	5	0.0216450216450216	231	10287	3815,4684,2905,816,2252	KIT,NCAM1,GRIN2C,CAMK2B,FGF7
R-HSA-2586552	Signaling by Leptin	0.675931931525628	-0.39166290101848	253	5	0.0216450216450216	231	10287	3815,4684,816,2905,2252	KIT,NCAM1,CAMK2B,GRIN2C,FGF7
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.679642889410699	-0.386187781389502	50	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-167044	Signalling to RAS	0.685953332789826	-0.37694568157343	256	5	0.0216450216450216	231	10287	816,2905,2252,4684,3815	CAMK2B,GRIN2C,FGF7,NCAM1,KIT
R-HSA-383280	Nuclear Receptor transcription pathway	0.686871813177101	-0.375607593431592	51	1	0.00432900432900433	231	10287	6097	RORC
R-HSA-112310	Neurotransmitter Release Cycle	0.686871813177101	-0.375607593431592	51	1	0.00432900432900433	231	10287	9256	TSPOAP1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.686871813177101	-0.375607593431592	51	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.686871813177101	-0.375607593431592	51	1	0.00432900432900433	231	10287	2209	FCGR1A
R-HSA-156580	Phase II conjugation	0.692251699453477	-0.367805661963366	106	2	0.00865800865800866	231	10287	2946,2953	GSTM2,GSTT2
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.692518011437977	-0.367421031962162	258	5	0.0216450216450216	231	10287	3815,4684,2905,816,2252	KIT,NCAM1,GRIN2C,CAMK2B,FGF7
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.693274904985353	-0.366328670161679	158	3	0.012987012987013	231	10287	7351,5166,23539	UCP2,PDK4,SLC16A8
R-HSA-382556	ABC-family proteins mediated transport	0.697195097663896	-0.360689996824136	107	2	0.00865800865800866	231	10287	5244,225	ABCB4,ABCD2
R-HSA-75153	Apoptotic execution  phase	0.70084599942495	-0.355467103065219	53	1	0.00432900432900433	231	10287	4137	MAPT
R-HSA-114604	GPVI-mediated activation cascade	0.707598449507591	-0.345878507897903	54	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.707598449507591	-0.345878507897903	54	1	0.00432900432900433	231	10287	6382	SDC1
R-HSA-187687	Signalling to ERKs	0.708520392116717	-0.344576438167197	263	5	0.0216450216450216	231	10287	3815,4684,2252,2905,816	KIT,NCAM1,FGF7,GRIN2C,CAMK2B
R-HSA-2871796	FCERI mediated MAPK activation	0.714757043086074	-0.335812593912806	265	5	0.0216450216450216	231	10287	816,2905,2252,4684,3815	CAMK2B,GRIN2C,FGF7,NCAM1,KIT
R-HSA-1280215	Cytokine Signaling in Immune system	0.729150892910103	-0.315874582232894	756	15	0.0649350649350649	231	10287	2162,6097,2209,5608,4684,1271,1154,5295,2905,2625,948,3815,816,2252,2317	F13A1,RORC,FCGR1A,MAP2K6,NCAM1,CNTFR,CISH,PIK3R1,GRIN2C,GATA3,CD36,KIT,CAMK2B,FGF7,FLNB
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.733124139263654	-0.310440233640009	58	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.733124139263654	-0.310440233640009	58	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.733124139263654	-0.310440233640009	58	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.733124139263654	-0.310440233640009	58	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.733124139263654	-0.310440233640009	58	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.735646119535593	-0.307006091730646	372	7	0.0303030303030303	231	10287	2549,2252,816,5295,2905,4684,3815	GAB1,FGF7,CAMK2B,PIK3R1,GRIN2C,NCAM1,KIT
R-HSA-2142753	Arachidonic acid metabolism	0.739150957496705	-0.302253106233448	59	1	0.00432900432900433	231	10287	5740	PTGIS
R-HSA-1280218	Adaptive Immune System	0.740707354414839	-0.300149665006057	810	16	0.0692640692640693	231	10287	948,3815,92591,2252,4008,974,2214,2209,5133,55740,5295,4068,54209,2549,929,3798	CD36,KIT,ASB16,FGF7,LMO7,CD79B,FCGR3A,FCGR1A,PDCD1,ENAH,PIK3R1,SH2D1A,TREM2,GAB1,CD14,KIF5A
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.745042248924246	-0.294314352245097	60	1	0.00432900432900433	231	10287	3549	IHH
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.750801048240321	-0.286614578106238	61	1	0.00432900432900433	231	10287	2735	GLI1
R-HSA-202403	TCR signaling	0.751532176121592	-0.285641254841952	119	2	0.00865800865800866	231	10287	5295,55740	PIK3R1,ENAH
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.756099581294333	-0.279582190188291	330	6	0.025974025974026	231	10287	816,5295,2905,2252,4684,3815	CAMK2B,PIK3R1,GRIN2C,FGF7,NCAM1,KIT
R-HSA-8873719	RAB geranylgeranylation	0.767311834178898	-0.264861996772792	64	1	0.00432900432900433	231	10287	25837	RAB26
R-HSA-450294	MAP kinase activation in TLR cascade	0.767311834178898	-0.264861996772792	64	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-1630316	Glycosaminoglycan metabolism	0.771586916546879	-0.259305954358087	124	2	0.00865800865800866	231	10287	6382,4958	SDC1,OMD
R-HSA-388396	GPCR downstream signaling	0.774655504689836	-0.255336858530313	974	19	0.0822510822510823	231	10287	5295,2149,4987,10268,107,27115,6755,5136,2359,27334,8622,2788,84033,5330,57449,5745,2147,56656,886	PIK3R1,F2R,OPRL1,RAMP3,ADCY1,PDE7B,SSTR5,PDE1A,FPR3,P2RY10,PDE8B,GNG7,OBSCN,PLCB2,PLEKHG5,PTH1R,F2,OR2S2,CCKAR
R-HSA-194138	Signaling by VEGF	0.775941691387135	-0.253677901587099	338	6	0.025974025974026	231	10287	5295,2905,816,2252,4684,3815	PIK3R1,GRIN2C,CAMK2B,FGF7,NCAM1,KIT
R-HSA-5358346	Hedgehog ligand biogenesis	0.782733112354908	-0.244963493770535	67	1	0.00432900432900433	231	10287	3549	IHH
R-HSA-5683057	MAPK family signaling cascades	0.784821643816626	-0.242298792343908	290	5	0.0216450216450216	231	10287	2252,816,2905,4684,3815	FGF7,CAMK2B,GRIN2C,NCAM1,KIT
R-HSA-216083	Integrin cell surface interactions	0.787643939287029	-0.238709144937566	68	1	0.00432900432900433	231	10287	7057	THBS1
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.792444237732134	-0.232633138189368	69	1	0.00432900432900433	231	10287	79090	TRAPPC6A
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.797136484858357	-0.226729366599332	70	1	0.00432900432900433	231	10287	81578	COL21A1
R-HSA-400253	Circadian Clock	0.801723102456131	-0.220991989514038	71	1	0.00432900432900433	231	10287	1628	DBP
R-HSA-199977	ER to Golgi Anterograde Transport	0.804155233503811	-0.217962951942761	133	2	0.00865800865800866	231	10287	288,79090	ANK3,TRAPPC6A
R-HSA-774815	Nucleosome assembly	0.806206458295183	-0.215415417545765	72	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.806206458295183	-0.215415417545765	72	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-1980143	Signaling by NOTCH1	0.81058886731599	-0.209994298763328	73	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-174824	Lipoprotein metabolism	0.814872592760828	-0.204723505862579	74	1	0.00432900432900433	231	10287	338	APOB
R-HSA-1169408	ISG15 antiviral mechanism	0.823152794403535	-0.194613440125558	76	1	0.00432900432900433	231	10287	2317	FLNB
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.823152794403535	-0.194613440125558	76	1	0.00432900432900433	231	10287	2317	FLNB
R-HSA-2262749	Cellular response to hypoxia	0.827153548924261	-0.18976493139336	77	1	0.00432900432900433	231	10287	10370	CITED2
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.827153548924261	-0.18976493139336	77	1	0.00432900432900433	231	10287	10370	CITED2
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.831064178703825	-0.185048256418302	78	1	0.00432900432900433	231	10287	493861	EID3
R-HSA-6807878	COPI-mediated anterograde transport	0.834886705395301	-0.180459245498255	79	1	0.00432900432900433	231	10287	288	ANK3
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.852745442809685	-0.159294201808263	84	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.852745442809685	-0.159294201808263	84	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.852745442809685	-0.159294201808263	84	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-168249	Innate Immune System	0.860614365224103	-0.150108766613646	1285	24	0.103896103896104	231	10287	338,2549,5136,929,730,5023,54209,122618,10396,816,5608,2209,107,2214,5295,2905,4684,143662,948,79895,2252,11001,4353,3815	APOB,GAB1,PDE1A,CD14,C7,P2RX1,TREM2,PLD4,ATP8A1,CAMK2B,MAP2K6,FCGR1A,ADCY1,FCGR3A,PIK3R1,GRIN2C,NCAM1,MUC15,CD36,ATP8B4,FGF7,SLC27A2,MPO,KIT
R-HSA-351202	Metabolism of polyamines	0.862523351802824	-0.147893055889133	87	1	0.00432900432900433	231	10287	2593	GAMT
R-HSA-6805567	Keratinization	0.86372331178162	-0.146502802459674	214	3	0.012987012987013	231	10287	3851,11005,6768	KRT4,SPINK5,ST14
R-HSA-3371556	Cellular response to heat stress	0.868680023344465	-0.140780434015595	89	1	0.00432900432900433	231	10287	816	CAMK2B
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.868680023344465	-0.140780434015595	89	1	0.00432900432900433	231	10287	79090	TRAPPC6A
R-HSA-2980736	Peptide hormone metabolism	0.874562118407457	-0.134031953990225	91	1	0.00432900432900433	231	10287	3798	KIF5A
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.877404031961031	-0.13078769490951	92	1	0.00432900432900433	231	10287	146760	RTN4RL1
R-HSA-5625740	RHO GTPases activate PKNs	0.880181831727774	-0.127626765890916	93	1	0.00432900432900433	231	10287	10398	MYL9
R-HSA-1474290	Collagen formation	0.880181831727774	-0.127626765890916	93	1	0.00432900432900433	231	10287	81578	COL21A1
R-HSA-15869	Metabolism of nucleotides	0.890680219190046	-0.115769816952986	97	1	0.00432900432900433	231	10287	26289	AK5
R-HSA-202424	Downstream TCR signaling	0.893158420310801	-0.112991311475858	98	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-390466	Chaperonin-mediated protein folding	0.895580680089205	-0.110282966521029	99	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-977225	Amyloid fiber formation	0.900262377184475	-0.105069027939527	101	1	0.00432900432900433	231	10287	6622	SNCA
R-HSA-597592	Post-translational protein modification	0.900839366625411	-0.104428320702796	1034	18	0.0779220779220779	231	10287	256435,2147,57134,7057,288,9719,146760,493861,129807,415,25837,143662,157869,374907,10417,338596,2625,79090	ST6GALNAC3,F2,MAN1C1,THBS1,ANK3,ADAMTSL2,RTN4RL1,EID3,NEU4,ARSE,RAB26,MUC15,SBSPON,B3GNT8,SPON2,ST8SIA6,GATA3,TRAPPC6A
R-HSA-109581	Apoptosis	0.902341099319015	-0.102762671513305	172	2	0.00865800865800866	231	10287	929,4137	CD14,MAPT
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.90473503582527	-0.100113156243709	103	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-2132295	MHC class II antigen presentation	0.90473503582527	-0.100113156243709	103	1	0.00432900432900433	231	10287	3798	KIF5A
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.906895896652139	-0.0977276131257522	104	1	0.00432900432900433	231	10287	493861	EID3
R-HSA-5357801	Programmed Cell Death	0.907585714336147	-0.0969672662442369	175	2	0.00865800865800866	231	10287	4137,929	MAPT,CD14
R-HSA-391251	Protein folding	0.909007950854057	-0.0954014380287672	105	1	0.00432900432900433	231	10287	2788	GNG7
R-HSA-71291	Metabolism of amino acids and derivatives	0.912697766463718	-0.0913504866369264	361	5	0.0216450216450216	231	10287	374569,2593,57571,2875,5053	ASPG,GAMT,CARNS1,GPT,PAH
R-HSA-73886	Chromosome Maintenance	0.916989689685956	-0.0866590503156467	109	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-72306	tRNA processing	0.916989689685956	-0.0866590503156467	109	1	0.00432900432900433	231	10287	57604	TRMT9B
R-HSA-2990846	SUMOylation	0.918873692594308	-0.084606606121919	110	1	0.00432900432900433	231	10287	493861	EID3
R-HSA-68877	Mitotic Prometaphase	0.920715117093565	-0.0826046096925061	111	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-157118	Signaling by NOTCH	0.922514921322937	-0.0806517283224544	112	1	0.00432900432900433	231	10287	3714	JAG2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.924274042029665	-0.0787466690290971	113	1	0.00432900432900433	231	10287	7351	UCP2
R-HSA-5653656	Vesicle-mediated transport	0.925039973170247	-0.077918328165315	650	10	0.0432900432900433	231	10287	113220,948,57134,90019,127833,338,5050,288,3798,79090	KIF12,CD36,MAN1C1,SYT8,SYT2,APOB,PAFAH1B3,ANK3,KIF5A,TRAPPC6A
R-HSA-6798695	Neutrophil degranulation	0.925967457036655	-0.0769161885424335	487	7	0.0303030303030303	231	10287	948,79895,10396,11001,4353,5023,929	CD36,ATP8B4,ATP8A1,SLC27A2,MPO,P2RX1,CD14
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.925997891965144	-0.0768833208340737	373	5	0.0216450216450216	231	10287	4008,948,2209,929,92591	LMO7,CD36,FCGR1A,CD14,ASB16
R-HSA-5663220	RHO GTPases Activate Formins	0.93092169877197	-0.0715801096760205	117	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-199991	Membrane Trafficking	0.936136642722449	-0.0659938273448545	610	9	0.038961038961039	231	10287	3798,79090,127833,338,5050,288,57134,90019,113220	KIF5A,TRAPPC6A,SYT2,APOB,PAFAH1B3,ANK3,MAN1C1,SYT8,KIF12
R-HSA-2262752	Cellular responses to stress	0.943555237040755	-0.0581003710639437	451	6	0.025974025974026	231	10287	6648,10370,2878,816,50507,5608	SOD2,CITED2,GPX3,CAMK2B,NOX4,MAP2K6
R-HSA-2559580	Oxidative Stress Induced Senescence	0.943830373275876	-0.0578088183091001	126	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-1500931	Cell-Cell communication	0.952184331841362	-0.0489966370500598	133	1	0.00432900432900433	231	10287	5295	PIK3R1
R-HSA-453279	Mitotic G1-G1/S phases	0.962017485004763	-0.0387226528009794	143	1	0.00432900432900433	231	10287	1028	CDKN1C
R-HSA-5621481	C-type lectin receptors (CLRs)	0.962882425934063	-0.0378239660873505	144	1	0.00432900432900433	231	10287	143662	MUC15
R-HSA-168256	Immune System	0.964097352445185	-0.0365630014568603	2101	37	0.16017316017316	231	10287	974,107,4008,1154,1271,4684,5133,948,3815,6097,3798,730,5023,54209,4068,122618,816,5608,2209,2214,2162,2625,5295,55740,2905,143662,79895,2252,92591,11001,4353,338,2549,5136,929,2317,10396	CD79B,ADCY1,LMO7,CISH,CNTFR,NCAM1,PDCD1,CD36,KIT,RORC,KIF5A,C7,P2RX1,TREM2,SH2D1A,PLD4,CAMK2B,MAP2K6,FCGR1A,FCGR3A,F13A1,GATA3,PIK3R1,ENAH,GRIN2C,MUC15,ATP8B4,FGF7,ASB16,SLC27A2,MPO,APOB,GAB1,PDE1A,CD14,FLNB,ATP8A1
R-HSA-5633007	Regulation of TP53 Activity	0.975490505425339	-0.0248148520003309	162	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-2467813	Separation of Sister Chromatids	0.97866068014687	-0.0215702949506905	168	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-68882	Mitotic Anaphase	0.983449738186052	-0.0166887475061582	179	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.98382796438686	-0.016304230155127	180	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-2559583	Cellular Senescence	0.988831753111619	-0.0112310800196188	196	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-5663205	Infectious disease	0.993362953663252	-0.00665916947129886	388	3	0.012987012987013	231	10287	5608,127833,9899	MAP2K6,SYT2,SV2B
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.993580063803319	-0.00644063261440573	311	2	0.00865800865800866	231	10287	4008,92591	LMO7,ASB16
R-HSA-5689880	Ub-specific processing proteases	0.99402849768019	-0.00598940303815064	223	1	0.00432900432900433	231	10287	2625	GATA3
R-HSA-392499	Metabolism of proteins	0.998986839517533	-0.00101367407647973	1619	21	0.0909090909090909	231	10287	79090,6622,2625,338596,10417,374907,143662,157869,25837,493861,146760,129807,3798,415,288,9719,2788,7057,57134,2147,256435	TRAPPC6A,SNCA,GATA3,ST8SIA6,SPON2,B3GNT8,MUC15,SBSPON,RAB26,EID3,RTN4RL1,NEU4,KIF5A,ARSE,ANK3,ADAMTSL2,GNG7,THBS1,MAN1C1,F2,ST6GALNAC3
R-HSA-5688426	Deubiquitination	0.999030773230431	-0.000969696773552669	301	1	0.00432900432900433	231	10287	2625	GATA3
R-HSA-68886	M Phase	0.999177276785525	-0.000823061836959792	308	1	0.00432900432900433	231	10287	401541	CENPP
R-HSA-73894	DNA Repair	0.9993178924712	-0.000682340269982578	316	1	0.00432900432900433	231	10287	4913	NTHL1
R-HSA-3700989	Transcriptional Regulation by TP53	0.999794238774438	-0.00020578239730721	367	1	0.00432900432900433	231	10287	5608	MAP2K6
R-HSA-381753	Olfactory Signaling Pathway	0.999883187366289	-0.000116819456837566	391	1	0.00432900432900433	231	10287	56656	OR2S2
R-HSA-69278	Cell Cycle, Mitotic	0.999915607370464	-8.43961907945497e-05	514	2	0.00865800865800866	231	10287	401541,1028	CENPP,CDKN1C
R-HSA-212436	Generic Transcription Pathway	0.999986737096033	-1.32629919195631e-05	865	5	0.0216450216450216	231	10287	5608,6097,10370,1490,3815	MAP2K6,RORC,CITED2,CCN2,KIT
R-HSA-1640170	Cell Cycle	0.999992242712246	-7.75731784157849e-06	621	2	0.00865800865800866	231	10287	401541,1028	CENPP,CDKN1C
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-68952	DNA replication initiation	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-196783	Coenzyme A biosynthesis	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-804914	Transport of fatty acids	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-444821	Relaxin receptors	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-73942	DNA Damage Reversal	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-164944	Nef and signal transduction	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-5576890	Phase 3 - rapid repolarisation	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-1483115	Hydrolysis of LPC	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-977347	Serine biosynthesis	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-72731	Recycling of eIF2:GDP	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-448424	Interleukin-17 signaling	0.999999999947834	-5.21663737174175e-11	8	0	0	231	10287
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-157858	Gap junction trafficking and regulation	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-917977	Transferrin endocytosis and recycling	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-420029	Tight junction interactions	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-5683826	Surfactant metabolism	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-5669034	TNFs bind their physiological receptors	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-8863795	Downregulation of ERBB2 signaling	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-381042	PERK regulates gene expression	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.999999999952021	-4.79794288674224e-11	30	0	0	231	10287
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.999999999952392	-4.76084918187108e-11	29	0	0	231	10287
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.999999999952392	-4.76084918187108e-11	29	0	0	231	10287
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.999999999952392	-4.76084918187108e-11	29	0	0	231	10287
R-HSA-72086	mRNA Capping	0.999999999952392	-4.76084918187108e-11	29	0	0	231	10287
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.999999999952392	-4.76084918187108e-11	29	0	0	231	10287
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.999999999952392	-4.76084918187108e-11	29	0	0	231	10287
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.999999999952392	-4.76084918187108e-11	29	0	0	231	10287
R-HSA-74160	Gene Expression	0.999999999956219	-4.37805274060842e-11	1821	6	0.025974025974026	231	10287	1490,10370,3815,5608,57604,6097	CCN2,CITED2,KIT,MAP2K6,TRMT9B,RORC
R-HSA-73772	RNA Polymerase I Promoter Escape	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-114452	Activation of BH3-only proteins	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-180786	Extension of Telomeres	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-418990	Adherens junctions interactions	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.999999999959227	-4.07726492910107e-11	31	0	0	231	10287
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-5656169	Termination of translesion DNA synthesis	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-5694530	Cargo concentration in the ER	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-113510	E2F mediated regulation of DNA replication	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-1483166	Synthesis of PA	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-73847	Purine metabolism	0.999999999959473	-4.05272036312516e-11	34	0	0	231	10287
R-HSA-75109	Triglyceride Biosynthesis	0.999999999961413	-3.85869994820953e-11	82	0	0	231	10287
R-HSA-380287	Centrosome maturation	0.999999999961413	-3.85869994820953e-11	82	0	0	231	10287
R-HSA-157579	Telomere Maintenance	0.999999999961413	-3.85869994820953e-11	82	0	0	231	10287
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.999999999961413	-3.85869994820953e-11	82	0	0	231	10287
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999961413	-3.85869994820953e-11	82	0	0	231	10287
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-198745	Signalling to STAT3	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-8875791	MET activates STAT3	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-73927	Depurination	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-111458	Formation of apoptosome	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5653890	Lactose synthesis	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-77108	Utilization of Ketone Bodies	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-191650	Regulation of gap junction activity	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-8849472	PTK6 Down-Regulation	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-977442	GABA A (rho) receptor activation	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-6806664	Metabolism of vitamin K	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-351200	Interconversion of polyamines	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-844455	The NLRP1 inflammasome	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-110331	Cleavage of the damaged purine	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-844615	The AIM2 inflammasome	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-1296067	Potassium transport channels	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-193681	Ceramide signalling	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-163282	Mitochondrial transcription initiation	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999964782	-3.52179742108742e-11	3	0	0	231	10287
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-1483152	Hydrolysis of LPE	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-916853	Degradation of GABA	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-198765	Signalling to ERK5	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-165160	PDE3B signalling	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-187042	TRKA activation by NGF	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5652227	Fructose biosynthesis	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-888568	GABA synthesis	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-70688	Proline catabolism	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-6804754	Regulation of TP53 Expression	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-71737	Pyrophosphate hydrolysis	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-168268	Virus Assembly and Release	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-156582	Acetylation	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-8854521	Interaction between PHLDA1 and AURKA	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-8849175	Threonine catabolism	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-380612	Metabolism of serotonin	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-844623	The IPAF inflammasome	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-111995	phospho-PLA2 pathway	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-8942233	Intestinal infectious diseases	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-351143	Agmatine biosynthesis	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-75896	Plasmalogen biosynthesis	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-75102	C6 deamination of adenosine	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-192905	vRNP Assembly	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-1483101	Synthesis of PS	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999965406	-3.45944091515588e-11	2	0	0	231	10287
R-HSA-68874	M/G1 Transition	0.999999999966146	-3.38537146173056e-11	86	0	0	231	10287
R-HSA-69002	DNA Replication Pre-Initiation	0.999999999966146	-3.38537146173056e-11	86	0	0	231	10287
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-110320	Translesion Synthesis by POLH	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-176412	Phosphorylation of the APC/C	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-8876725	Protein methylation	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-156584	Cytosolic sulfonation of small molecules	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-190861	Gap junction assembly	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.999999999967229	-3.27713590538231e-11	19	0	0	231	10287
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-209968	Thyroxine biosynthesis	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-190873	Gap junction degradation	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-70635	Urea cycle	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-74259	Purine catabolism	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-428643	Organic anion transporters	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-3215018	Processing and activation of SUMO	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-201688	WNT mediated activation of DVL	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-8868766	rRNA processing in the mitochondrion	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-727802	Transport of nucleotide sugars	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-74749	Signal attenuation	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-418886	Netrin mediated repulsion signals	0.999999999967714	-3.22855066683202e-11	10	0	0	231	10287
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-73848	Pyrimidine metabolism	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-379716	Cytosolic tRNA aminoacylation	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-1474165	Reproduction	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-1187000	Fertilization	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-912694	Regulation of IFNA signaling	0.99999999996783	-3.21703272704716e-11	26	0	0	231	10287
R-HSA-167169	HIV Transcription Elongation	0.999999999968003	-3.19970243310488e-11	50	0	0	231	10287
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.999999999968003	-3.19970243310488e-11	50	0	0	231	10287
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.999999999968003	-3.19970243310488e-11	50	0	0	231	10287
R-HSA-73893	DNA Damage Bypass	0.999999999968003	-3.19970243310488e-11	50	0	0	231	10287
R-HSA-6802949	Signaling by RAS mutants	0.999999999968003	-3.19970243310488e-11	50	0	0	231	10287
R-HSA-73887	Death Receptor Signalling	0.999999999968003	-3.19970243310488e-11	50	0	0	231	10287
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.999999999968207	-3.1792990192686e-11	24	0	0	231	10287
R-HSA-156588	Glucuronidation	0.999999999968207	-3.1792990192686e-11	24	0	0	231	10287
R-HSA-191273	Cholesterol biosynthesis	0.999999999968207	-3.1792990192686e-11	24	0	0	231	10287
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.999999999968207	-3.1792990192686e-11	24	0	0	231	10287
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999968207	-3.1792990192686e-11	24	0	0	231	10287
R-HSA-73728	RNA Polymerase I Promoter Opening	0.999999999968537	-3.14625815580122e-11	63	0	0	231	10287
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.999999999968537	-3.14625815580122e-11	63	0	0	231	10287
R-HSA-156842	Eukaryotic Translation Elongation	0.999999999968668	-3.13319057560146e-11	96	0	0	231	10287
R-HSA-72764	Eukaryotic Translation Termination	0.999999999968668	-3.13319057560146e-11	96	0	0	231	10287
R-HSA-168325	Viral Messenger RNA Synthesis	0.99999999996875	-3.12499673077899e-11	43	0	0	231	10287
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.99999999996875	-3.12499673077899e-11	43	0	0	231	10287
R-HSA-375280	Amine ligand-binding receptors	0.99999999996875	-3.12499673077899e-11	43	0	0	231	10287
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.99999999996875	-3.12499673077899e-11	43	0	0	231	10287
R-HSA-75893	TNF signaling	0.99999999996875	-3.12499673077899e-11	43	0	0	231	10287
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-977441	GABA A receptor activation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-171007	p38MAPK events	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-1502540	Signaling by Activin	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-2168880	Scavenging of heme from plasma	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-175474	Assembly Of The HIV Virion	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-75892	Platelet Adhesion to exposed collagen	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-190372	FGFR3c ligand binding and activation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-74217	Purine salvage	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-140342	Apoptosis induced DNA fragmentation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-350054	Notch-HLH transcription pathway	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-71240	Tryptophan catabolism	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-75205	Dissolution of Fibrin Clot	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-2408517	SeMet incorporation into proteins	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-190375	FGFR2c ligand binding and activation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-375281	Hormone ligand-binding receptors	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-190239	FGFR3 ligand binding and activation	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-211227	Activation of DNA fragmentation factor	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-202670	ERKs are inactivated	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-2995410	Nuclear Envelope Reassembly	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-5626467	RHO GTPases activate IQGAPs	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.999999999968754	-3.12461200548188e-11	13	0	0	231	10287
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-182971	EGFR downregulation	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-1538133	G0 and Early G1	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-162588	Budding and maturation of HIV virion	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-211981	Xenobiotics	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-3000157	Laminin interactions	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-933542	TRAF6 mediated NF-kB activation	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-5673000	RAF activation	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-429947	Deadenylation of mRNA	0.999999999968802	-3.11985067151242e-11	25	0	0	231	10287
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-169131	Inhibition of PKR	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-6809583	Retinoid metabolism disease events	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-164516	Minus-strand DNA synthesis	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1839128	FGFR4 mutant receptor activation	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1222499	Response of Mtb to phagocytosis	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-163316	Mitochondrial transcription termination	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-140180	COX reactions	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-2033515	t(4;14) translocations of FGFR3	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1300645	Acrosome Reaction	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-389542	NADPH regeneration	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1222449	Mtb iron assimilation by chelation	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-162589	Reverse Transcription of HIV RNA	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5602410	TLR3 deficiency - HSE	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1483076	Synthesis of CL	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5602415	UNC93B1 deficiency - HSE	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-8853333	Signaling by FGFR2 fusions	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-164525	Plus-strand DNA synthesis	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-3248023	Regulation by TREX1	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-171286	Synthesis and processing of ENV and VPU	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-2408552	Methylation of MeSeH for excretion	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-2534343	Interaction With Cumulus Cells	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-162585	Uncoating of the HIV Virion	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.99999999996947	-3.0530109690341e-11	1	0	0	231	10287
R-HSA-6784531	tRNA processing in the nucleus	0.999999999970008	-2.99922515046941e-11	60	0	0	231	10287
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.999999999970008	-2.99922515046941e-11	60	0	0	231	10287
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.999999999970008	-2.99922515046941e-11	60	0	0	231	10287
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.999999999970008	-2.99922515046941e-11	60	0	0	231	10287
R-HSA-399956	CRMPs in Sema3A signaling	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-1170546	Prolactin receptor signaling	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-159418	Recycling of bile acids and salts	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-392517	Rap1 signalling	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-110312	Translesion synthesis by REV1	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-190242	FGFR1 ligand binding and activation	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-5218859	Regulated Necrosis	0.999999999970258	-2.97422448431192e-11	16	0	0	231	10287
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-166663	Initial triggering of complement	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-1482801	Acyl chain remodelling of PS	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-166208	mTORC1-mediated signalling	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-198753	ERK/MAPK targets	0.999999999970371	-2.96289734796087e-11	22	0	0	231	10287
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.999999999970489	-2.95106532178293e-11	41	0	0	231	10287
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.999999999970489	-2.95106532178293e-11	41	0	0	231	10287
R-HSA-5620924	Intraflagellar transport	0.999999999970489	-2.95106532178293e-11	41	0	0	231	10287
R-HSA-5696400	Dual Incision in GG-NER	0.999999999970489	-2.95106532178293e-11	41	0	0	231	10287
R-HSA-74158	RNA Polymerase III Transcription	0.999999999970489	-2.95106532178293e-11	41	0	0	231	10287
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-171319	Telomere Extension By Telomerase	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-3595177	Defective CHSY1 causes TPBS	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-75158	TRAIL  signaling	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-162791	Attachment of GPI anchor to uPAR	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-447038	NrCAM interactions	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-174362	Transport and synthesis of PAPS	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-199920	CREB phosphorylation	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-448706	Interleukin-1 processing	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-111471	Apoptotic factor-mediated response	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-174577	Activation of C3 and C5	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-164843	2-LTR circle formation	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-5619102	SLC transporter disorders	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-429593	Inositol transporters	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-196791	Vitamin D (calciferol) metabolism	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-190371	FGFR3b ligand binding and activation	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-447043	Neurofascin interactions	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-5603029	IkBA variant leads to EDA-ID	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-426117	Cation-coupled Chloride cotransporters	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.999999999970693	-2.93068482743523e-11	7	0	0	231	10287
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.999999999970802	-2.91982798540681e-11	64	0	0	231	10287
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5358508	Mismatch Repair	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-156581	Methylation	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-69183	Processive synthesis on the lagging strand	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5682910	LGI-ADAM interactions	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-3371568	Attenuation phase	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-205043	NRIF signals cell death from the nucleus	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999971	-2.89996292132156e-11	15	0	0	231	10287
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.999999999972159	-2.7840714166478e-11	39	0	0	231	10287
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.999999999972159	-2.7840714166478e-11	39	0	0	231	10287
R-HSA-5674135	MAP2K and MAPK activation	0.999999999972159	-2.7840714166478e-11	39	0	0	231	10287
R-HSA-6783310	Fanconi Anemia Pathway	0.999999999972159	-2.7840714166478e-11	39	0	0	231	10287
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.999999999972159	-2.7840714166478e-11	39	0	0	231	10287
R-HSA-165159	mTOR signalling	0.999999999972159	-2.7840714166478e-11	39	0	0	231	10287
R-HSA-69618	Mitotic Spindle Checkpoint	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-210745	Regulation of gene expression in beta cells	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-6807004	Negative regulation of MET activity	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-1181150	Signaling by NODAL	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-5423646	Aflatoxin activation and detoxification	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-2028269	Signaling by Hippo	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.999999999972973	-2.7026751061731e-11	21	0	0	231	10287
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.999999999973777	-2.62226239872063e-11	81	0	0	231	10287
R-HSA-2559585	Oncogene Induced Senescence	0.999999999973821	-2.61784558115181e-11	32	0	0	231	10287
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.999999999973821	-2.61784558115181e-11	32	0	0	231	10287
R-HSA-69190	DNA strand elongation	0.999999999973821	-2.61784558115181e-11	32	0	0	231	10287
R-HSA-68962	Activation of the pre-replicative complex	0.999999999973821	-2.61784558115181e-11	32	0	0	231	10287
R-HSA-73863	RNA Polymerase I Transcription Termination	0.999999999973821	-2.61784558115181e-11	32	0	0	231	10287
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.999999999973821	-2.61784558115181e-11	32	0	0	231	10287
R-HSA-6804757	Regulation of TP53 Degradation	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-113418	Formation of the Early Elongation Complex	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-5693537	Resolution of D-Loop Structures	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-933541	TRAF6 mediated IRF7 activation	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.999999999973979	-2.60206346079859e-11	35	0	0	231	10287
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-1482925	Acyl chain remodelling of PG	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-69205	G1/S-Specific Transcription	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-209776	Amine-derived hormones	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.999999999974182	-2.58177541845673e-11	18	0	0	231	10287
R-HSA-69109	Leading Strand Synthesis	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-2024101	CS/DS degradation	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-69166	Removal of the Flap Intermediate	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-209952	Peptide hormone biosynthesis	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-69091	Polymerase switching	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-209560	NF-kB is activated and signals survival	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-428540	Activation of Rac	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-5675482	Regulation of necroptotic cell death	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-877312	Regulation of IFNG signaling	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-174403	Glutathione synthesis and recycling	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-162594	Early Phase of HIV Life Cycle	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-190322	FGFR4 ligand binding and activation	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-418885	DCC mediated attractive signaling	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-177504	Retrograde neurotrophin signalling	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999974265	-2.57345870598694e-11	14	0	0	231	10287
R-HSA-3371378	Regulation by c-FLIP	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-5661231	Metallothioneins bind metals	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-376172	DSCAM interactions	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-189451	Heme biosynthesis	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-8851805	MET activates RAS signaling	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-193048	Androgen biosynthesis	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-69416	Dimerization of procaspase-8	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-196780	Biotin transport and metabolism	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-211999	CYP2E1 reactions	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-73614	Pyrimidine salvage reactions	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-549127	Organic cation transport	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-5660526	Response to metal ions	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-75072	mRNA Editing	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-5218900	CASP8 activity is inhibited	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-1059683	Interleukin-6 signaling	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-446107	Type I hemidesmosome assembly	0.999999999974448	-2.55515097778089e-11	11	0	0	231	10287
R-HSA-68949	Orc1 removal from chromatin	0.999999999974649	-2.53514208543374e-11	72	0	0	231	10287
R-HSA-69052	Switching of origins to a post-replicative state	0.999999999974649	-2.53514208543374e-11	72	0	0	231	10287
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.999999999974649	-2.53514208543374e-11	72	0	0	231	10287
R-HSA-69202	Cyclin E associated events during G1/S transition	0.999999999974649	-2.53514208543374e-11	72	0	0	231	10287
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	0.999999999974649	-2.53514208543374e-11	72	0	0	231	10287
R-HSA-4570464	SUMOylation of RNA binding proteins	0.99999999997477	-2.52302932234316e-11	48	0	0	231	10287
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.99999999997477	-2.52302932234316e-11	48	0	0	231	10287
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.99999999997477	-2.52302932234316e-11	48	0	0	231	10287
R-HSA-6803157	Antimicrobial peptides	0.999999999974883	-2.5116838316933e-11	97	0	0	231	10287
R-HSA-5676934	Protein repair	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-6799990	Metal sequestration by antimicrobial proteins	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-1566977	Fibronectin matrix formation	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-190370	FGFR1b ligand binding and activation	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-205025	NADE modulates death signalling	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-3065679	SUMO is proteolytically processed	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-176417	Phosphorylation of Emi1	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-1237112	Methionine salvage pathway	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-166662	Lectin pathway of complement activation	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-500753	Pyrimidine biosynthesis	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-444257	RSK activation	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-189483	Heme degradation	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-388479	Vasopressin-like receptors	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-428808	Na+-dependent glucose transporters	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-211916	Vitamins	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-187015	Activation of TRKA receptors	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999975146	-2.48542568341481e-11	6	0	0	231	10287
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.999999999975253	-2.47464833900046e-11	52	0	0	231	10287
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.999999999975253	-2.47464833900046e-11	52	0	0	231	10287
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.999999999975253	-2.47464833900046e-11	52	0	0	231	10287
R-HSA-2980766	Nuclear Envelope Breakdown	0.999999999975253	-2.47464833900046e-11	52	0	0	231	10287
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.999999999975253	-2.47464833900046e-11	52	0	0	231	10287
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.999999999975253	-2.47464833900046e-11	52	0	0	231	10287
R-HSA-3214842	HDMs demethylate histones	0.999999999975253	-2.47464833900046e-11	52	0	0	231	10287
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.999999999975499	-2.4500556796862e-11	44	0	0	231	10287
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.999999999975499	-2.4500556796862e-11	44	0	0	231	10287
R-HSA-5689896	Ovarian tumor domain proteases	0.99999999997562	-2.43799706455348e-11	37	0	0	231	10287
R-HSA-176187	Activation of ATR in response to replication stress	0.99999999997562	-2.43799706455348e-11	37	0	0	231	10287
R-HSA-421837	Clathrin derived vesicle budding	0.99999999997612	-2.38803848513647e-11	73	0	0	231	10287
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.99999999997612	-2.38803848513647e-11	73	0	0	231	10287
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.99999999997612	-2.38803848513647e-11	73	0	0	231	10287
R-HSA-3214841	PKMTs methylate histone lysines	0.99999999997612	-2.38803848513647e-11	73	0	0	231	10287
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.99999999997612	-2.38803848513647e-11	73	0	0	231	10287
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.99999999997612	-2.38803848513647e-11	73	0	0	231	10287
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.999999999976162	-2.3837751295936e-11	100	0	0	231	10287
R-HSA-1442490	Collagen degradation	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-5675221	Negative regulation of MAPK pathway	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-167287	HIV elongation arrest and recovery	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-109703	PKB-mediated events	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-167290	Pausing and recovery of HIV elongation	0.999999999976199	-2.38006383201566e-11	40	0	0	231	10287
R-HSA-5619084	ABC transporter disorders	0.999999999976939	-2.30613720666662e-11	69	0	0	231	10287
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.999999999976939	-2.30613720666662e-11	69	0	0	231	10287
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	0.999999999976939	-2.30613720666662e-11	69	0	0	231	10287
R-HSA-68867	Assembly of the pre-replicative complex	0.999999999976939	-2.30613720666662e-11	69	0	0	231	10287
R-HSA-909733	Interferon alpha/beta signaling	0.999999999976939	-2.30613720666662e-11	69	0	0	231	10287
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.999999999976939	-2.30613720666662e-11	69	0	0	231	10287
R-HSA-1461973	Defensins	0.999999999977123	-2.28770276143989e-11	51	0	0	231	10287
R-HSA-171306	Packaging Of Telomere Ends	0.999999999977123	-2.28770276143989e-11	51	0	0	231	10287
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.999999999977123	-2.28770276143989e-11	51	0	0	231	10287
R-HSA-6799198	Complex I biogenesis	0.999999999977123	-2.28770276143989e-11	51	0	0	231	10287
R-HSA-8868773	rRNA processing in the nucleus and cytosol	0.999999999977245	-2.27550274980816e-11	191	0	0	231	10287
R-HSA-1632852	Macroautophagy	0.999999999977318	-2.26817887852764e-11	67	0	0	231	10287
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999977318	-2.26817887852764e-11	67	0	0	231	10287
R-HSA-69615	G1/S DNA Damage Checkpoints	0.999999999977318	-2.26817887852764e-11	67	0	0	231	10287
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.999999999977318	-2.26817887852764e-11	67	0	0	231	10287
R-HSA-8848021	Signaling by PTK6	0.999999999977318	-2.26817887852764e-11	67	0	0	231	10287
R-HSA-912446	Meiotic recombination	0.999999999977433	-2.25667391632709e-11	88	0	0	231	10287
R-HSA-446728	Cell junction organization	0.999999999977433	-2.25667391632709e-11	88	0	0	231	10287
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.999999999977433	-2.25667391632709e-11	88	0	0	231	10287
R-HSA-5389840	Mitochondrial translation elongation	0.999999999977433	-2.25667391632709e-11	88	0	0	231	10287
R-HSA-69481	G2/M Checkpoints	0.999999999977696	-2.23044493461511e-11	169	0	0	231	10287
R-HSA-73776	RNA Polymerase II Promoter Escape	0.999999999977761	-2.22389515406769e-11	47	0	0	231	10287
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.999999999977761	-2.22389515406769e-11	47	0	0	231	10287
R-HSA-167161	HIV Transcription Initiation	0.999999999977761	-2.22389515406769e-11	47	0	0	231	10287
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.999999999977761	-2.22389515406769e-11	47	0	0	231	10287
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.999999999977761	-2.22389515406769e-11	47	0	0	231	10287
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.999999999977761	-2.22389515406769e-11	47	0	0	231	10287
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.999999999977761	-2.22389515406769e-11	47	0	0	231	10287
R-HSA-4615885	SUMOylation of DNA replication proteins	0.999999999977855	-2.21453812467415e-11	46	0	0	231	10287
R-HSA-70153	Glucose transport	0.999999999977855	-2.21453812467415e-11	46	0	0	231	10287
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.999999999977855	-2.21453812467415e-11	46	0	0	231	10287
R-HSA-4641265	Repression of WNT target genes	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-190373	FGFR1c ligand binding and activation	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-2033514	FGFR3 mutant receptor activation	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-211958	Miscellaneous substrates	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-844456	The NLRP3 inflammasome	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-5578768	Physiological factors	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-71064	Lysine catabolism	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-209822	Glycoprotein hormones	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-203615	eNOS activation	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-176974	Unwinding of DNA	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-1236977	Endosomal/Vacuolar pathway	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-5689877	Josephin domain DUBs	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-8851680	Butyrophilin (BTN) family interactions	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-390666	Serotonin receptors	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-3371511	HSF1 activation	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-8866427	VLDLR internalisation and degradation	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-389359	CD28 dependent Vav1 pathway	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-210990	PECAM1 interactions	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-2160916	Hyaluronan uptake and degradation	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-166786	Creation of C4 and C2 activators	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-73621	Pyrimidine catabolism	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999978352	-2.16484303010829e-11	12	0	0	231	10287
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-73980	RNA Polymerase III Transcription Termination	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-5205647	Mitophagy	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-112409	RAF-independent MAPK1/3 activation	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999978425	-2.15745278707016e-11	23	0	0	231	10287
R-HSA-5419276	Mitochondrial translation termination	0.999999999978629	-2.13713495062632e-11	87	0	0	231	10287
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.999999999978629	-2.13713495062632e-11	87	0	0	231	10287
R-HSA-453276	Regulation of mitotic cell cycle	0.999999999978629	-2.13713495062632e-11	87	0	0	231	10287
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.999999999978629	-2.13713495062632e-11	87	0	0	231	10287
R-HSA-5368286	Mitochondrial translation initiation	0.999999999978629	-2.13713495062632e-11	87	0	0	231	10287
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.999999999978859	-2.11413161672803e-11	99	0	0	231	10287
R-HSA-1368082	RORA activates gene expression	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-437239	Recycling pathway of L1	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-190828	Gap junction trafficking	0.999999999978903	-2.10969138053518e-11	28	0	0	231	10287
R-HSA-5658442	Regulation of RAS by GAPs	0.999999999978943	-2.10570246467328e-11	70	0	0	231	10287
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.999999999978943	-2.10570246467328e-11	70	0	0	231	10287
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.999999999979152	-2.08478406915688e-11	126	0	0	231	10287
R-HSA-5619507	Activation of HOX genes during differentiation	0.999999999979152	-2.08478406915688e-11	126	0	0	231	10287
R-HSA-211000	Gene Silencing by RNA	0.999999999979877	-2.01225381339506e-11	137	0	0	231	10287
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.999999999979877	-2.01225381339506e-11	137	0	0	231	10287
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-72702	Ribosomal scanning and start codon recognition	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-6802952	Signaling by BRAF and RAF fusions	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-421270	Cell-cell junction organization	0.999999999980504	-1.94962044875502e-11	61	0	0	231	10287
R-HSA-159424	Conjugation of carboxylic acids	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-419771	Opsins	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-196025	Formation of annular gap junctions	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-390696	Adrenoceptors	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-75094	Formation of the Editosome	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-447041	CHL1 interactions	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-425986	Sodium/Proton exchangers	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-1300642	Sperm Motility And Taxes	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-1462054	Alpha-defensins	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-2214320	Anchoring fibril formation	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-162592	Integration of provirus	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-156587	Amino Acid conjugation	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-391908	Prostanoid ligand receptors	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	0.999999999980802	-1.91979528797736e-11	9	0	0	231	10287
R-HSA-4641258	Degradation of DVL	0.999999999980814	-1.91864462729429e-11	59	0	0	231	10287
R-HSA-69304	Regulation of DNA replication	0.999999999980815	-1.91847731686926e-11	77	0	0	231	10287
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.999999999980815	-1.91847731686926e-11	77	0	0	231	10287
R-HSA-167172	Transcription of the HIV genome	0.999999999980815	-1.91847731686926e-11	77	0	0	231	10287
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.999999999980815	-1.91847731686926e-11	77	0	0	231	10287
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.999999999981187	-1.88127054779632e-11	71	0	0	231	10287
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.999999999981187	-1.88127054779632e-11	71	0	0	231	10287
R-HSA-73856	RNA Polymerase II Transcription Termination	0.999999999981187	-1.88127054779632e-11	71	0	0	231	10287
R-HSA-177243	Interactions of Rev with host cellular proteins	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-2514856	The phototransduction cascade	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-432720	Lysosome Vesicle Biogenesis	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.999999999981207	-1.87924869006949e-11	36	0	0	231	10287
R-HSA-212300	PRC2 methylates histones and DNA	0.999999999981372	-1.8627974319693e-11	74	0	0	231	10287
R-HSA-69300	Removal of licensing factors from origins	0.999999999981372	-1.8627974319693e-11	74	0	0	231	10287
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.999999999981372	-1.8627974319693e-11	74	0	0	231	10287
R-HSA-2299718	Condensation of Prophase Chromosomes	0.999999999981372	-1.8627974319693e-11	74	0	0	231	10287
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-8853383	Lysosomal oligosaccharide catabolism	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-8849473	PTK6 Expression	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-6785470	tRNA processing in the mitochondrion	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-8875513	MET interacts with TNS proteins	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-2142850	Hyaluronan biosynthesis and export	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-71262	Carnitine synthesis	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-390651	Dopamine receptors	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-8866376	Reelin signalling pathway	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-74713	IRS activation	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-114516	Disinhibition of SNARE formation	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-2161517	Abacavir transmembrane transport	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-68911	G2 Phase	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-70370	Galactose catabolism	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-1169092	Activation of RAS in B cells	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-1614517	Sulfide oxidation to sulfate	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-5662702	Melanin biosynthesis	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-187024	NGF-independant TRKA activation	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-112307	Transmission across Electrical Synapses	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-75157	FasL/ CD95L signaling	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-446205	Synthesis of GDP-mannose	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-71032	Propionyl-CoA catabolism	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-1483226	Synthesis of PI	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-111463	SMAC binds to IAPs	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-391906	Leukotriene receptors	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-157881	Cyclin B2 mediated events	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-444209	Free fatty acid receptors	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-426048	Arachidonate production from DAG	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-112303	Electric Transmission Across Gap Junctions	0.999999999981423	-1.85768441454844e-11	5	0	0	231	10287
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.999999999981714	-1.82863868298301e-11	83	0	0	231	10287
R-HSA-5693607	Processing of DNA double-strand break ends	0.999999999982395	-1.76046670598365e-11	98	0	0	231	10287
R-HSA-1461957	Beta defensins	0.999999999982407	-1.75930800178894e-11	42	0	0	231	10287
R-HSA-373752	Netrin-1 signaling	0.999999999982407	-1.75930800178894e-11	42	0	0	231	10287
R-HSA-168253	Host Interactions with Influenza Factors	0.999999999982407	-1.75930800178894e-11	42	0	0	231	10287
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	0.999999999982407	-1.75930800178894e-11	42	0	0	231	10287
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.999999999982407	-1.75930800178894e-11	42	0	0	231	10287
R-HSA-167060	NGF processing	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-209905	Catecholamine biosynthesis	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-417973	Adenosine P1 receptors	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-8935690	Miscellaneous digestion events	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-165158	Activation of AKT2	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-6783984	Glycine degradation	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-173107	Binding and entry of HIV virion	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-1296053	Classical Kir channels	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-8849474	PTK6 Activates STAT3	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-888593	Reuptake of GABA	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-173736	Alternative complement activation	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-447115	Interleukin-12 signaling	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-209563	Axonal growth stimulation	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-428776	Class II GLUTs	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-442745	Activation of CaMK IV	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-1296061	HCN channels	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-8848584	Wax biosynthesis	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-140179	Amine Oxidase reactions	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-390650	Histamine receptors	0.999999999982463	-1.7537200659652e-11	4	0	0	231	10287
R-HSA-379724	tRNA Aminoacylation	0.999999999982508	-1.74917659764807e-11	45	0	0	231	10287
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.999999999982508	-1.74917659764807e-11	45	0	0	231	10287
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.999999999982508	-1.74917659764807e-11	45	0	0	231	10287
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999982508	-1.74917659764807e-11	45	0	0	231	10287
R-HSA-8854214	TBC/RABGAPs	0.999999999982508	-1.74917659764807e-11	45	0	0	231	10287
R-HSA-72649	Translation initiation complex formation	0.999999999983238	-1.67616322208149e-11	62	0	0	231	10287
R-HSA-72187	mRNA 3'-end processing	0.999999999983238	-1.67616322208149e-11	62	0	0	231	10287
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.999999999983238	-1.67616322208149e-11	62	0	0	231	10287
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999983238	-1.67616322208149e-11	62	0	0	231	10287
R-HSA-6790901	rRNA modification in the nucleus and cytosol	0.999999999983238	-1.67616322208149e-11	62	0	0	231	10287
R-HSA-8852135	Protein ubiquitination	0.999999999983238	-1.67616322208149e-11	62	0	0	231	10287
R-HSA-1268020	Mitochondrial protein import	0.999999999983238	-1.67616322208149e-11	62	0	0	231	10287
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.999999999983645	-1.63551977679603e-11	104	0	0	231	10287
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.999999999984704	-1.52957054862931e-11	85	0	0	231	10287
R-HSA-1500620	Meiosis	0.999999999985121	-1.48792919807008e-11	121	0	0	231	10287
R-HSA-2408522	Selenoamino acid metabolism	0.999999999985121	-1.48792919807008e-11	121	0	0	231	10287
R-HSA-427413	NoRC negatively regulates rRNA expression	0.999999999985129	-1.48712089919403e-11	107	0	0	231	10287
R-HSA-168255	Influenza Life Cycle	0.999999999985266	-1.47343097297924e-11	146	0	0	231	10287
R-HSA-3214815	HDACs deacetylate histones	0.999999999985394	-1.46059108396353e-11	94	0	0	231	10287
R-HSA-5368287	Mitochondrial translation	0.999999999985394	-1.46059108396353e-11	94	0	0	231	10287
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.999999999986213	-1.37873368467068e-11	65	0	0	231	10287
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.999999999986213	-1.37873368467068e-11	65	0	0	231	10287
R-HSA-112382	Formation of RNA Pol II elongation complex	0.999999999986213	-1.37873368467068e-11	65	0	0	231	10287
R-HSA-5334118	DNA methylation	0.999999999986213	-1.37873368467068e-11	65	0	0	231	10287
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.999999999986213	-1.37873368467068e-11	65	0	0	231	10287
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.999999999986213	-1.37873368467068e-11	65	0	0	231	10287
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	0.999999999986335	-1.36648096856675e-11	56	0	0	231	10287
R-HSA-69541	Stabilization of p53	0.999999999986335	-1.36648096856675e-11	56	0	0	231	10287
R-HSA-381038	XBP1(S) activates chaperone genes	0.999999999986335	-1.36648096856675e-11	56	0	0	231	10287
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.999999999986335	-1.36648096856675e-11	56	0	0	231	10287
R-HSA-4641257	Degradation of AXIN	0.999999999986335	-1.36648096856675e-11	56	0	0	231	10287
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.999999999986534	-1.3465912160478e-11	75	0	0	231	10287
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.999999999986534	-1.3465912160478e-11	75	0	0	231	10287
R-HSA-8854518	AURKA Activation by TPX2	0.999999999986534	-1.3465912160478e-11	75	0	0	231	10287
R-HSA-6802957	Oncogenic MAPK signaling	0.999999999986534	-1.3465912160478e-11	75	0	0	231	10287
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	0.999999999987166	-1.28344131253058e-11	49	0	0	231	10287
R-HSA-6783783	Interleukin-10 signaling	0.999999999987166	-1.28344131253058e-11	49	0	0	231	10287
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.999999999987166	-1.28344131253058e-11	49	0	0	231	10287
R-HSA-622312	Inflammasomes	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-3232118	SUMOylation of transcription factors	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-2142845	Hyaluronan metabolism	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-196299	Beta-catenin phosphorylation cascade	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-156711	Polo-like kinase mediated events	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-5656121	Translesion synthesis by POLI	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-435354	Zinc transporters	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-5655862	Translesion synthesis by POLK	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-193639	p75NTR signals via NF-kB	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-189445	Metabolism of porphyrins	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-192456	Digestion of dietary lipid	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.999999999987321	-1.26786220794031e-11	17	0	0	231	10287
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.999999999987464	-1.25364407352615e-11	53	0	0	231	10287
R-HSA-180534	Vpu mediated degradation of CD4	0.999999999987464	-1.25364407352615e-11	53	0	0	231	10287
R-HSA-191859	snRNP Assembly	0.999999999987464	-1.25364407352615e-11	53	0	0	231	10287
R-HSA-72165	mRNA Splicing - Minor Pathway	0.999999999987464	-1.25364407352615e-11	53	0	0	231	10287
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.999999999987464	-1.25364407352615e-11	53	0	0	231	10287
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.999999999987464	-1.25364407352615e-11	53	0	0	231	10287
R-HSA-194441	Metabolism of non-coding RNA	0.999999999987464	-1.25364407352615e-11	53	0	0	231	10287
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.999999999988207	-1.17928787260703e-11	247	0	0	231	10287
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.999999999988301	-1.1699166142669e-11	93	0	0	231	10287
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.999999999988301	-1.1699166142669e-11	93	0	0	231	10287
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.999999999988451	-1.15490522749592e-11	84	0	0	231	10287
R-HSA-2408557	Selenocysteine synthesis	0.999999999988556	-1.1443781243234e-11	95	0	0	231	10287
R-HSA-69473	G2/M DNA damage checkpoint	0.999999999988556	-1.1443781243234e-11	95	0	0	231	10287
R-HSA-72312	rRNA processing	0.999999999988671	-1.13288602274739e-11	201	0	0	231	10287
R-HSA-69620	Cell Cycle Checkpoints	0.999999999988671	-1.13288602274739e-11	201	0	0	231	10287
R-HSA-901042	Calnexin/calreticulin cycle	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-114508	Effects of PIP2 hydrolysis	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-1482788	Acyl chain remodelling of PC	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-380994	ATF4 activates genes	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-77387	Insulin receptor recycling	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	0.999999999988828	-1.11718250636706e-11	27	0	0	231	10287
R-HSA-168254	Influenza Infection	0.999999999988922	-1.10775636940151e-11	157	0	0	231	10287
R-HSA-73857	RNA Polymerase II Transcription	0.999999999989188	-1.08123786484023e-11	159	0	0	231	10287
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-69186	Lagging Strand Synthesis	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-194223	HDL-mediated lipid transport	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-6804760	Regulation of TP53 Activity through Methylation	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-8874081	MET activates PTK2 signaling	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.999999999989425	-1.05747934568977e-11	20	0	0	231	10287
R-HSA-611105	Respiratory electron transport	0.9999999999897	-1.02996828576234e-11	92	0	0	231	10287
R-HSA-381119	Unfolded Protein Response (UPR)	0.9999999999897	-1.02996828576234e-11	92	0	0	231	10287
R-HSA-192823	Viral mRNA Translation	0.9999999999897	-1.02996828576234e-11	92	0	0	231	10287
R-HSA-156902	Peptide chain elongation	0.9999999999897	-1.02996828576234e-11	92	0	0	231	10287
R-HSA-68875	Mitotic Prophase	0.999999999990043	-9.95749118325422e-12	141	0	0	231	10287
R-HSA-72689	Formation of a pool of free 40S subunits	0.999999999990113	-9.88692685127318e-12	105	0	0	231	10287
R-HSA-5689603	UCH proteinases	0.999999999990113	-9.88692685127318e-12	105	0	0	231	10287
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.999999999990644	-9.35562358614059e-12	54	0	0	231	10287
R-HSA-169911	Regulation of Apoptosis	0.999999999990644	-9.35562358614059e-12	54	0	0	231	10287
R-HSA-189200	Hexose transport	0.999999999990644	-9.35562358614059e-12	54	0	0	231	10287
R-HSA-1592230	Mitochondrial biogenesis	0.999999999990644	-9.35562358614059e-12	54	0	0	231	10287
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.999999999990644	-9.35562358614059e-12	54	0	0	231	10287
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.999999999990644	-9.35562358614059e-12	54	0	0	231	10287
R-HSA-69610	p53-Independent DNA Damage Response	0.999999999990644	-9.35562358614059e-12	54	0	0	231	10287
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.999999999990748	-9.25231440883773e-12	110	0	0	231	10287
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.999999999990748	-9.25231440883773e-12	110	0	0	231	10287
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.999999999990748	-9.25231440883773e-12	110	0	0	231	10287
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.999999999990765	-9.2353824301504e-12	57	0	0	231	10287
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.999999999990765	-9.2353824301504e-12	57	0	0	231	10287
R-HSA-429914	Deadenylation-dependent mRNA decay	0.999999999990765	-9.2353824301504e-12	57	0	0	231	10287
R-HSA-72172	mRNA Splicing	0.999999999990793	-9.20674862015619e-12	195	0	0	231	10287
R-HSA-6782135	Dual incision in TC-NER	0.999999999991042	-8.95802565962357e-12	66	0	0	231	10287
R-HSA-5357905	Regulation of TNFR1 signaling	0.999999999991237	-8.7628542925943e-12	33	0	0	231	10287
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.999999999991237	-8.7628542925943e-12	33	0	0	231	10287
R-HSA-180746	Nuclear import of Rev protein	0.999999999991237	-8.7628542925943e-12	33	0	0	231	10287
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.999999999991237	-8.7628542925943e-12	33	0	0	231	10287
R-HSA-1222556	ROS, RNS production in phagocytes	0.999999999991237	-8.7628542925943e-12	33	0	0	231	10287
R-HSA-186712	Regulation of beta-cell development	0.999999999991237	-8.7628542925943e-12	33	0	0	231	10287
R-HSA-72766	Translation	0.999999999991436	-8.56369126660386e-12	162	0	0	231	10287
R-HSA-5693532	DNA Double-Strand Break Repair	0.999999999992121	-7.87891749685249e-12	167	0	0	231	10287
R-HSA-162906	HIV Infection	0.999999999992248	-7.75197482056884e-12	236	0	0	231	10287
R-HSA-5687128	MAPK6/MAPK4 signaling	0.999999999992398	-7.60247290514792e-12	90	0	0	231	10287
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.999999999992398	-7.60247290514792e-12	90	0	0	231	10287
R-HSA-73864	RNA Polymerase I Transcription	0.99999999999297	-7.02996108223766e-12	112	0	0	231	10287
R-HSA-5696398	Nucleotide Excision Repair	0.99999999999297	-7.02996108223766e-12	112	0	0	231	10287
R-HSA-73777	RNA Polymerase I Chain Elongation	0.99999999999323	-6.76997697619172e-12	91	0	0	231	10287
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.99999999999323	-6.76997697619172e-12	91	0	0	231	10287
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.99999999999323	-6.76997697619172e-12	91	0	0	231	10287
R-HSA-162909	Host Interactions of HIV factors	0.999999999993536	-6.46425078450402e-12	134	0	0	231	10287
R-HSA-5578749	Transcriptional regulation by small RNAs	0.999999999993907	-6.09266300966552e-12	106	0	0	231	10287
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.999999999993944	-6.05606292370493e-12	115	0	0	231	10287
R-HSA-5693538	Homology Directed Repair	0.999999999994095	-5.90481724492776e-12	138	0	0	231	10287
R-HSA-4839726	Chromatin organization	0.999999999994102	-5.89822257428762e-12	279	0	0	231	10287
R-HSA-3247509	Chromatin modifying enzymes	0.999999999994102	-5.89822257428762e-12	279	0	0	231	10287
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.999999999994273	-5.72664711922563e-12	101	0	0	231	10287
R-HSA-69239	Synthesis of DNA	0.999999999994273	-5.72664711922563e-12	101	0	0	231	10287
R-HSA-69275	G2/M Transition	0.999999999994592	-5.40812775767926e-12	182	0	0	231	10287
R-HSA-3214847	HATs acetylate histones	0.999999999994664	-5.33558267068115e-12	143	0	0	231	10287
R-HSA-162599	Late Phase of HIV Life Cycle	0.99999999999548	-4.52044491485287e-12	139	0	0	231	10287
R-HSA-5689901	Metalloprotease DUBs	0.999999999995509	-4.49077023837765e-12	38	0	0	231	10287
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.999999999995509	-4.49077023837765e-12	38	0	0	231	10287
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.999999999995509	-4.49077023837765e-12	38	0	0	231	10287
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.999999999995509	-4.49077023837765e-12	38	0	0	231	10287
R-HSA-69206	G1/S Transition	0.999999999995692	-4.30751595957736e-12	119	0	0	231	10287
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999995749	-4.25139336517807e-12	76	0	0	231	10287
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.999999999995749	-4.25139336517807e-12	76	0	0	231	10287
R-HSA-5693606	DNA Double Strand Break Response	0.999999999995749	-4.25139336517807e-12	76	0	0	231	10287
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.999999999995749	-4.25139336517807e-12	76	0	0	231	10287
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.999999999995852	-4.14785939606482e-12	120	0	0	231	10287
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.999999999995852	-4.14785939606482e-12	120	0	0	231	10287
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.999999999996834	-3.16649615512826e-12	58	0	0	231	10287
R-HSA-381070	IRE1alpha activates chaperones	0.999999999996834	-3.16649615512826e-12	58	0	0	231	10287
R-HSA-453274	Mitotic G2-G2/M phases	0.999999999996932	-3.06770449358731e-12	184	0	0	231	10287
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.99999999999728	-2.7204837997587e-12	55	0	0	231	10287
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.99999999999728	-2.7204837997587e-12	55	0	0	231	10287
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.99999999999728	-2.7204837997587e-12	55	0	0	231	10287
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.999999999997509	-2.49084175841392e-12	117	0	0	231	10287
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.999999999997509	-2.49084175841392e-12	117	0	0	231	10287
R-HSA-69242	S Phase	0.999999999998002	-1.99782646771419e-12	130	0	0	231	10287
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.999999999998397	-1.6026080688562e-12	149	0	0	231	10287
R-HSA-69306	DNA Replication	0.999999999999313	-6.87193769790134e-13	109	0	0	231	10287
R-HSA-3214858	RMTs methylate histone arginines	1.00000000000015	1.47223365858953e-13	79	0	0	231	10287
R-HSA-2871837	FCERI mediated NF-kB activation	1.00000000000015	1.47223365858953e-13	79	0	0	231	10287
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1.00000000000015	1.47223365858953e-13	79	0	0	231	10287
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.00000000000015	1.47223365858953e-13	79	0	0	231	10287
R-HSA-1221632	Meiotic synapsis	1.00000000000015	1.47223365858953e-13	79	0	0	231	10287
R-HSA-212165	Epigenetic regulation of gene expression	1.00000000000091	9.12041667928101e-13	151	0	0	231	10287
R-HSA-162587	HIV Life Cycle	1.00000000000154	1.5446585816096e-12	152	0	0	231	10287
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	1.0000000000018	1.79573798265367e-12	108	0	0	231	10287
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1.00000000000184	1.83569181680665e-12	68	0	0	231	10287
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	1.00000000000184	1.83569181680665e-12	68	0	0	231	10287
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000000184	1.83569181680665e-12	68	0	0	231	10287
R-HSA-1169091	Activation of NF-kappaB in B cells	1.00000000000184	1.83569181680665e-12	68	0	0	231	10287
R-HSA-1852241	Organelle biogenesis and maintenance	1.00000000000238	2.37785562089314e-12	340	0	0	231	10287
R-HSA-72163	mRNA Splicing - Major Pathway	1.00000000000326	3.26409566144288e-12	187	0	0	231	10287
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	1.00000000000708	7.08006352824131e-12	132	0	0	231	10287
R-HSA-72613	Eukaryotic Translation Initiation	1.0000000000081	8.10287099786656e-12	125	0	0	231	10287
R-HSA-72737	Cap-dependent Translation Initiation	1.0000000000081	8.10287099786656e-12	125	0	0	231	10287
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.00000000000898	8.97932712572205e-12	179	0	0	231	10287
R-HSA-5617833	Cilium Assembly	1.00000000001413	1.41304582297422e-11	192	0	0	231	10287
